Investigating Biological Properties Utilizing Synthetic Methods by Chatkewitz, Lindsay E
W&M ScholarWorks 
Undergraduate Honors Theses Theses, Dissertations, & Master Projects 
4-2017 
Investigating Biological Properties Utilizing Synthetic Methods 
Lindsay E. Chatkewitz 
College of William and Mary 
Follow this and additional works at: https://scholarworks.wm.edu/honorstheses 
 Part of the Biochemistry Commons, and the Organic Chemistry Commons 
Recommended Citation 
Chatkewitz, Lindsay E., "Investigating Biological Properties Utilizing Synthetic Methods" (2017). 
Undergraduate Honors Theses. Paper 1060. 
https://scholarworks.wm.edu/honorstheses/1060 
This Honors Thesis is brought to you for free and open access by the Theses, Dissertations, & Master Projects at 
W&M ScholarWorks. It has been accepted for inclusion in Undergraduate Honors Theses by an authorized 
administrator of W&M ScholarWorks. For more information, please contact scholarworks@wm.edu. 
	
	
1	akjsdksjd;kdsj;skdjfs;dkfj
	
	
1 
 
Investigating Biological Properties Utilizing Synthetic Methods 
 
 
 
 
 
Lindsay E. Chatkewitz 
Glenelg, Maryland 
 
 
 
 
 
 
 
 
A Thesis Presented at the College of William and Mary in Candidacy for Honors 
 
 
 
 
 
 
 
 
 
 
 
 
Chemistry Department 
 
 
 
 
 
 
 
 
 
 
 
The College of William and Mary 
April 25th, 2017 
  
	
	
2 
Table of Contents 
 
 
Abstract………………………………………………………………………6 
Chapter 1: Introduction………………………………………………………7 
 Protein Building Blocks……………………………………………...7 
 The Central Dogma………………………………………………….8 
 Unnatural Amino Acids and Protein Expression…………………....11 
 Photocaging…………………………………………………………14 
 Green Fluorescent Protein…………………………………………..15 
 Conclusion…………………………………………………………...16 
Chapter 2: A Photocaged Tyrosine UAA Possessing  
an Alkyne Moiety……………………………………………………………17 
 Results and Discussion………………………………………………18 
 Experimental…………………………………………………………27 
Chapter 3: Development of a Copper-Free Microwave 
Mediated 1,3-Dipolar Cycloaddition………………………………………...34 
 Results and Discussion………………………………………………37 
 Experimental………………………………………………………....44  
Chapter 4: Optimization of the Glaser-Hay Reaction 
in a Biological System……………………………………………………….50 
 Results and Discussion………………………………………………52 
 Experimental…………………………………………………………59  
Chapter 5: Fluorescent Labeling of T3 Hormone……………………………62 
 Results and Discussion……………………………………………….63 
 Experimental…………………………………………………………66  
Chapter 6: Selection of an Aminoacyl tRNA  
Synthetase to Incorporate a Photocaged Selenocysteine…………………….68 
 Results and Discussion………………………………………………71 
 Experimental…………………………………………………………73  
References……………………………………………………………………77  
Acknowledgements…………………………………………………………..81  
  
	
	
3 
Table of Figures 
 
 
Chapter 1: Introduction 
 1.1 Structure of an amino ac………………………………………...8 
 1.2 The Central Dogma…………………………………………..….8 
 1.3 Lac Operon Schematic………………………..…………………....10 
 1.4 Natural and Unnatural Amino Acid 
     Incorporation………………………………………………………...13 
 1.5 General Decaging Schematic……………………………………14 
 1.6 Enhanced GFP and its 
     chromophore………………………………………………….......15 
Chapter 2: A Photocaged Tyrosine UAA Possessing an Alkyne Moiety 
 2.1 Bioconjugaation to an Antibody………………………………….17 
 2.2 SDS-PAGE Analysis of Glaser-Hay Bioconjugation  
     Using Photocaged Alkyne UAA………………………...…………24 
Chapter 3: Development of a Copper-Free Microwave Mediated  
1,3-Dipolar Cycloaddition 
 3.1 General Copper-Catalyzed Azide-Alkyne 
      Cycloaddition Reaction……..……………………………………34 
 3.2 Microwave……………………………………………………….35  
Chapter 4: Optimization of the Glaser-Hay Reaction in a  
Biological System 
 4.1 p-Propargyloxyphenyalanine UAA………………………………52 
 4.2 SDS-PAGE Analysis of Glaser-Hay Reactions 
       Testing Reducing Agents…………….……………………………53  
4.3 SDS-PAGE Analysis of Glaser-Hay Reactions 
       Testing Copper Sources…………….…………………………….55 
4.4 SDS-PAGE Analysis of Glaser-Hay Reactions 
       Testing Radical Scavengers…………….………………………...56 
4.5 Ligands Used in Glaser-Hay Optimization...................................57 
4.6 SDS-PAGE Analysis of Glaser-Hay Reactions 
       Testing Ligands…………….…………..…………………………58 
Chapter 5: Fluorescent Labeling of T3 Hormone 
 5.1 Triiodothyronine (T3)…………………………………………….62 
 5.2 Fluorescein Isothiocyanate………………………………………63  
 5.3 Fluorescent Red 630……………………………………………..65 
Chapter 6: Selection of an Aminoacyl tRNA Synthetase to Incorporate a  
Photocaged Selenocysteine 
 6.1 Photocleavable Selenocysteine UAA…………………………….68 
 6.2 Aminoacyl tRNA Synthetase Selection Scheme………………….70  
 
  
	
	
4 
Table of Schemes 
 
 
 Chapter 2: A Photocaged Tyrosine UAA Possessing an Alkyne Moiety 
 2.1 Synthesis of a caged alkynyl tyrosine amino acid….…………….19 
 2.2 Propargylation of Vanillin……..……………………...…………20 
 2.3 Addition of a nitro group...............................................................20 
 2.4 Reduction of an aldehyde to an alcohol…………………………20 
 2.5 Bromination……………………………………………………...21 
 2.6 Addition of a protecting group…………………………………..21 
 2.7 Deprotection……………………………………………………..22 
 2.8 Decaging of ortho-nitrobenzyl group……………………………25 
Chapter 3: Development of a Copper-Free Microwave Mediated  
1,3-Dipolar Cycloaddition 
 3.1 Copper-Catalyzed Azide-Alkyne 
      Cycloaddition Reaction……..……………………………………34 
 3.2 Copper-free microwave mediated Azide-Alkyne 
            Cycloaddition Reaction …………………………………………35 
 3.3 Benzyl azide and phenylacetylene microwave 
      mediated cycloaddition…………………………………………..37 
 3.4 Trityl chloride protection of propargyl alcohol………………....43  
Chapter 4: Optimization of the Glaser-Hay Reaction in a  
Biological System 
 4.1 Glaser-Hay coupling…………………………………………….50 
Chapter 5: Fluorescent Labeling of T3 Hormone 
 5.1 Labeling of Triiodothyronine with Fluorescein  
     Isothiocyanate…………………………………………………….64  
 5.3 Labeling of Triiodothyronine with  
     Fluorescent Red 630………………………………………….…..65 
Chapter 6: Selection of an Aminoacyl tRNA Synthetase to Incorporate a  
Photocaged Selenocysteine 
 6.1 Synthesis of a photocleavable Selenocysteine UAA…….……….68 
 
 
  
	
	
5 
Table of Tables 
 
 
 Chapter 3: Development of a Copper-Free Microwave Mediated  
1,3-Dipolar Cycloaddition 
 3.1 Optimization of microwave mediated azide 
      alkyne cycloaddiion……..……………………………….………40 
 3.2 Yields for microwave mediated azide 
      alkyne cycloaddition reactions.…………………………………41 
  
 
 
 
 
 
  
	
	
6 
Abstract 
 
 The growing field of bioorganic chemistry employs interesting tools and methods 
that can be used to study the intersection of chemistry and biology. This thesis aims to 
explore bioorganic chemistry, highlighting techniques that encourage the study of 
biology from a chemical perspective. The development of a photocaged, alkyne-
containing unnatural amino acid (UAA) as well as a photocaged selenocysteine UAA 
highlight the diversity of of what can potentially be incorporated into proteins while also 
concentrating on the diversity of the functions of UAAs. Development of copper-free 
microwave mediated azide-alkyne cycloaddition reactions and development of an 
optimized aqueous Glaser-Hay reaction focuses on another aspect of bioorganic 
chemistry – adjusting chemical reactions so they can ultimately be used in a biological 
setting. Lastly, fluorescent labeling of T3 hormone is explored, showing where the 
applications of bioorganic chemistry allow for in depth study of biological systems.  
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Chapter 1: Introduction 
  
Within the human body, there are trillions of cells working together in order to 
sustain life. However, each individual cell is maintained by an even smaller entity: the 
protein. Proteins are responsible for a wide range of functions, including structure, 
movement, defense, and regulation.1 With all this responsibility, it is incredible that a 
protein essentially is “an unbranched polymer of 20 different amino acids”.1 
Interestingly, each of the hundreds of thousands of proteins in the human body, with such 
a diverse range of functions, only differ in their arrangement of just 20 common 
canonical, or endogenous, amino acids. These amino acids are also limited in their 
chemical functionality. Only five chemical elements are present in amino acids, and 
many functional groups, such as azides or alkynes, are not present within these natural 
amino acids. Since protein functions range from metabolism to regulation of the cell to 
structural support, it is astonishing that the only differences between each protein are how 
many amino acids they are made up of, and how those amino acids are arranged. With 
that in mind, it is even more astonishing to think of the possibilities that could become 
reality if a protein could be altered to have a new functionality introduced by a novel 
amino acid.  
Protein Building Blocks  
 Proteins are built from biomolecules called amino acids. Amino acids are 
molecules that have the same backbone, comprised of a central carbon between an amine 
group and carboxylic acid group (Figure 1.1).1 The differences between amino acids arise 
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from what is attached to the chiral carbon, commonly referred to as the side chain. Side 
chains of different amino acids have very different characteristics.  
These groups can give amino acids polar, nonpolar, acidic, 
or basic characteristics.1 They can also affect the structural 
flexibility of the amino acid, which in turn, can affect the 
protein’s overall structure.1 Along with the endogenous 
amino acids, it is also possible to prepare a class of amino 
acids called nonstandard, or unnatural amino acids (UAAs).1 These amino acids may be 
found in living organisms but are not incorporated into proteins, or can be chemically 
synthesized and do not exist in biological systems.1  
The Central Dogma  
 All prokaryotic and eukaryotic cells contain DNA that encodes the information 
for all proteins the cell requires to survive. DNA is made up of nucleotides connected via 
a phosphodiester backbone, which stores genetic information based on the sequence of 
four different nitrogenous bases.1 In DNA those bases are adenine (A), guanine (G), 
cytosine (C), and thymine (T).1 These 
sequences can either encode for a protein, or 
they can act as a regulatory sequence to 
regulate the production of specific proteins.1  
Two processes are required for the 
information encoded in the DNA in a gene to 
be converted into a functional protein. These 
processes comprise the central dogma, where 
+H3N OH
O
R
Figure	1.1:	Structure	of	an	amino	acid
Figure	1.2:	The	central	dogma2
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DNA must first be transcribed into messenger RNA (mRNA), then translated into a 
protein (Figure 1.2). Messenger RNA is single-stranded and specifies the sequence of a 
protein in its own set of nitrogenous bases.1 Adenine (A), guanine (G), and cytosine (C) 
are used in mRNA as well as DNA, but thymine (T) is replaced by uracil (U).1 
Transcription of mRNA allows for the transport of genetic information out of the nucleus 
in eukaryotes and into the cytoplasm where the machinery for protein production is 
present. Many copies of mRNA can be made to produce many copies of a protein. This is 
much more efficient than using a single copy of the gene from the DNA. 
 Translation allows the information stored in the mRNA to be converted to a 
protein context.1 The mRNA is processed by a ribosome in sets of three nitrogenous 
bases, called codons.1 The ribosome scans the mRNA for a very specific start codon.1 
Once that codon has been identified, the linking of amino acids begins. Amino acids are 
introduced into the ribosome by transfer RNA (tRNA). This tRNA contains an anticodon 
that recognizes the complementary codon on the mRNA and allows the correct amino 
acid to be incorporated in response to the codon. In order for the tRNA to transport an 
amino acid, the tRNA must first be charged with a specific amino acid by an enzyme 
called an aminoacyl tRNA synthetase (aaRS).1 Each synthetase is specific to one amino 
acid and one tRNA, and by default each tRNA is specific to one amino acid.1 The 
aminoacylated tRNA brings the amino acid to the ribosome so that it can be coupled by a 
peptide bond with the next amino acid in the protein.1 In order to end translation, a stop 
codon must be encountered by the ribosome.1 There are three different stop codons that 
are used to end translation; UAA, UAG, and UGA.1 
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 Transcription and translation are the processes that facilitate gene expression, 
which enables cells to produce proteins in response to different environmental factors. In 
order to do this, genes may need to be turned on and off to conserve the energy of the 
cell, making gene expression a highly regulated process.1 Some genes (constitutive 
genes) must be expressed at all times because they encode products that are required for 
the cell to function normally. Other genes are inducible, which means they are expressed 
only under certain circumstances.1 In order to control inducible genes, a regulatory 
sequence in the DNA controls whether or not the gene is transcribed to RNA.1 In 
prokaryotes, often multiple genes located next to each other are all induced at the same 
time by a single regulatory sequence, or operator.1 When these genes are all controlled by 
one operator, that group is known as an operon.1  
One of the most well studied operons is the lac operon in the bacterium E.coli. It 
was originally discovered in the 
1950s by Francois Jacob and 
Jacques Monod.1 The genes in the 
operon are used for enzymes that 
control lactose metabolism.1 
These enzymes are only needed 
when lactose is present in the 
cell.1 In order to control 
production of the enzymes, a protein, called the lac repressor protein, binds to the 
regulatory sequence of the operon and the operon is not transcribed as RNA polymerase 
is prevented access to the DNA (Figure 1.3).1 When lactose is brought into the cell, a 
Figure	1.3:	Lac	operon	schematic 1
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small amount is converted to allolactose.1 Allolactose then binds to the lac repressor 
protein to change its conformation and cause it to release from the operator.1 The lac 
operon remains active until the lactose supply is used up, at which point the lac repressor 
protein binds the operator again and the operon is turned off.1  
Unnatural Amino Acids and Protein Expression 
Unnatural amino acids (UAAs) afford an opportunity for the expansion of protein 
functionality. It is possible that new functionalities may confer evolutionary advantages 
to proteins.3 Chemically reactive groups can be engineered into proteins in order to 
perform reactions in vivo that cannot be performed using the 20 endogenous amino 
acids.4 Moreover, with the incorporation of new functional groups via UAAs, the 
catalytic ability of proteins could also be enhanced.3 Fluorescent probing is one important 
technique that takes advantage of unnatural amino acid incorporation.4 Currently, 
proteins are  modified to have fluorescent properties using genetic fusion and non-site 
specific protein modifications. This allows protein interactions to be monitored in real 
time.3 Protein localization can also be monitored, allowing a new understanding of 
specific protein function. Along with an understanding of protein function, incorporation 
of heavy atoms into a protein can allow for X-ray structure determination.3 Looking at 
proteins in this manner can give information about how the protein folds and the final 
shape of the protein. Using unnatural amino acids to incorporate these modifications into 
proteins can allow for a much deeper understanding of the mechanisms of the human 
body.  
 Chemically reactive groups with a wide range of functionalities have already been 
incorporated into proteins. Esters, cyano, sulfo, and selenium containing groups have all 
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been incorporated into proteins. Each of these groups possesses their own range of 
reactivity and usefulness.3 For example, new redox chemistries can be performed with 
selenium containing UAAs, and chemistries such as the azide-alkyne cycloddition 
reaction can be performed between azide groups and alkyne groups, neither of which 
occurs naturally in proteins. The 20 endogenous amino acids do not possess the chemical 
diversity needed for many of these applications, illustrating a key advantage to UAA 
incorporation  
 Addition of UAAs into proteins can be accomplished by various different 
methods. Two popular methods are site-specific incorporation, where a UAA is 
incorporated into one specific site using the translational machinery, or residue-specific 
incorporation where one natural amino acid is completely replaced with a UAA along the 
entirety of the protein.5 Residue-specific incorporation into a protein allows for broad 
changes in the amino acid sequence of the protein, and multiple sites can be changed at 
once.5,6 Site-specific incorporation is generally used for investigating mechanistic 
questions, as one amino acid change can alter the function of the protein.5 Site-specific 
incorporation permits a greater degree of control, but residue-specific incorporation 
allows for greater change of the protein more quickly. 
 Expression of UAAs in proteins also can be done in two ways. Researchers can 
either charge the tRNA with the UAA in vitro or in vivo. This section will focus on 
protein expression in vivo as it has been more successful, giving higher yields, higher 
fidelity of expression, and this method does not require a chemical reaction to 
aminoacylate the tRNA.4 
	
	
13 
 In order to express protein in vivo, 
researchers exploit the biological 
machinery already present in cells. To do 
this, a plasmid must first be introduced 
into the cell. This plasmid carries copies 
of the tRNA and aminoacyl tRNA 
synthetase (aaRS) genes needed.7 The 
tRNAs and aaRSs endogenous to the cell 
cannot be used to incorporate UAAs 
because they are specific to the 20 natural amino acids already found in the cell and 
would result in a loss of control over the process.3 Modified tRNA and aaRS genes from 
archaeal or mammalian cells are often introduced into bacterial cells to incorporate an 
UAA. The different organism provides a degree of bioorthogonality, preventing cross 
talk between the endogenous system and the UAA machinery. Prior to being introduced 
into cells, the tRNA and aaRS have been evolved via several rounds of positive and 
negative selections to ensure that they incorporate the unnatural amino acid with high 
fidelity, and that they do not incorporate any endogenous amino acids in the absence of 
the desired UAA.3 
 Along with introducing a plasmid into a cell, the gene for the protein that will 
contain the UAA must be introduced. In order to utilize site-specific incorporation, a 
codon of the DNA for the gene of interest must be modified to include a blank codon, 
which is a codon that does not encode for any of the 20 natural amino acids.4 A common 
example of a blank codon is any of the three stop codons used to terminate translation. In 
Figure	1.4:	A	side-by-side	comparison	of	the	mechanism	of	
natural	and	unnatural	 in	vivo amino	acid	incorporation.4
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E. coli, the TAG/UAG codon in commonly used because it is used the least.4 During 
translation of the protein, a stop codon in the mRNA (made from the mutated DNA) 
would normally terminate translation. However, if there is a tRNA charged with the 
unnatural amino acid in the cell, and if it can respond to that stop codon, then 
incorporation of the unnatural amino acid will occur and translation will continue.  
Photocaging 
 Introducing new, reactive moieties into a cell can present problems in terms of 
controlling the novel functionality. One 
solution to this problem is a process called 
photocaging. Photocaging employs a 
deactivating caging group that can be 
removed under certain wavelengths of non-damaging UV light to restore reactivity, 
providing an external and non-toxic trigger.8,9 
 A standard caging group relies on ortho-nitrobenzyl moieties. These groups can 
be integrated into an amino acid context to afford site-specific photocaging. This strategy 
offers a high level of control of the protein in terms of when and where it is activated, and 
the ability to externally modulate the protein.10,11,12 However, once a photocaging group 
is removed, deactivation of the protein cannot resume, as there is no reversibility 
associated with this method.11  
Photocaging has been employed in a wide variety of experiments. Ortho-
nitrobenzyl groups have been added to RNA polymerases and small molecule inducers in 
order to control transcription in cells.8,13 Using this method, transcription of genes can be 
controlled temporally by choosing when to irradiate the bacterial cells, but also spatially 
Figure	1.5:	A	general	decagingmechanism.	Ortho-nitrobenzyl
is	a	commonly	used	caging	group.13
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by choosing which cells to irradiate, affording unique spatio-temporal control. Moreover, 
caging groups have been used to increase control of reactive amino acids in proteins.13 In 
some cases, caging just one amino acid that is critical to the function of the protein can 
prevent an entire cellular process. In one experiment, DNA recombination in human 
embryo kidney cells was stopped by caging a single tyrosine residue.13 After irradiation 
with UV light, 70% of the original functionality was restored. In another study, the 
incorporation of a caged tyrosine into an RNA polymerase enzyme rendered the enzyme 
inactive.8 However, upon irradiation with UV light for just two minutes, 70% of the wild-
type activity was restored.8 This method has proven to be a very powerful technique for 
allowing researchers to control biological processes.  
Green Fluorescent Protein 
Green fluorescent protein (GFP) is a protein found in the deep sea jellyfish 
species Aequorea victoria.14 As its name suggests, it emits a green glow after excitation 
with blue light (395 nm) which can be used as a marker in a cell, or as a way to track 
movement of molecules through the cell, proving GFP’s usefulness in bioanalytical 
applications.14,15,16,18 It is favored over other proteins that can emit light because the 
chromophore (Figure 1.6) found within the protein does not require any additional 
cofactors to fluoresce.16 Thus, when using 
GFP, no additional molecules are needed to 
produce the fluorescence; only the protein 
needs to be produced in the cell. GFP is also 
advantageous because an intact protein is 
needed for fluorescence.16 If protein translation 
Figure	1.6:	Enhanced	GFP	and	its	
chromophore.	 It	is	the	most	widely	used	
fluorescent	marker.	 17
	
	
16 
stops in the middle of the mRNA sequence, there will be no GFP expressed in the cell. 
This can potentially be used to monitor effective stop codon suppression in the process of 
site-specific UAA incorporation. Genes for the expression of GFP can also be inserted 
into a genome, and GFP can be expressed inside of a cell without any interference to cell 
growth or function.16  
 GFP is made up of only 238 amino acid residues.16 The chromophore of the 
protein is found in residues 65-67, which consists of a serine-tyrosine-glycine sequence 
in the wild type protein.14 These residues react to form a p-
hydroxybenzylideneimidazolinone in the chromophore. Interestingly, the glycine 67 
residue is conserved in all known fluorescent protein derivatives of GFP.14  
Conclusion 
 The body has developed a very fast and efficient mechanism for synthesizing 
extremely large proteins that have a stunningly wide range of functionalities. By 
incorporating unnatural amino acids into proteins, the elements and functional groups 
used in proteins increases exponentially. New elements and functional groups on proteins 
can lead to tools for research to examine mechanisms of diseases that could lead to novel 
treatments and cures. Incorporation of unnatural amino acids can also lead to new designs 
for medicine. Pairing this powerful technique with photochemistry introduces another 
layer of control over this process, which can greatly enhance the ability of researchers to 
use this technology with precision and accuracy. This technique represents not only an 
advancement in science, but also an advancement in our biological function. The work 
outlined in this thesis aims to take advantage of some of the methods and biological 
properties outlined in order to expand the scope of bioorganic chemistry. 
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Chapter 2: A Photocaged Tyrosine UAA Possessing an 
Alkyne Moiety 
 
 In addition to the ability to control protein function, site-specific incorporation of 
UAAs has proven especially useful in the generation of novel bioconjugates. A 
bioconjugate can be broadly defined as the association between a biomolecule and a 
secondary component.19 Bioconjugation offers a powerful tool to modify proteins 
through coupling with biophysical probes, therapeutic agents, or surfaces.20,21,22,23 Many 
bioconjugation techniques use covalent linkages to bind such effector molecules to the 
proteins. For example, bioconjugation of drugs with polyethylene glycol (PEG) chains 
reduces drug degradation and immunogenicity.22 Many of these covalent linking 
strategies, despite their utility, suffer from a lack of specificity, and often result in 
proteins conjugated to multiple partners. To achieve greater specificity, UAAs have been 
genetically encoded into proteins that allow for directed covalent linkages. Substantial 
research has been conducted employing a variety of different UAAs in several 
bioorthogonal reactions to prepare well-defined bioconjugates.25,26,27,28,29 One example 
involves the preparation of bispecific antibodies by generating Fab fragments with a p-
Figure	2.1:	Bioconjugation	 of	a	terminal	alkoxy-amine	 functionalized	anti-cancer	drug	through	an	oxime ligation	to	an	IgG	
molecule.31
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acetylphenylalanine UAA, capable of undergoing oxime ligations forming therapeutically 
useful bioconjugates.28,30 
Due to the well-documented utility of both bioconjugates and photocaging, 
discussed previously, this research aimed to combine the two techniques into a single 
UAA. The gap in the current bioorganic technology prompted this interest in developing 
such a bifunctional UAA. Ideally, this UAA would harbor a handle for bioconjugation 
reactions such as the Glaser-Hay reaction, linking two terminal alkynes, or the azide-
alkyne cycloaddition reaction, linking an azide and an alkyne to form a 1,2,3-triazole. In 
addition to bioconjugation functionality, the UAA designed should facilitate a degree of 
conjugate flexibility, allowing it to dissociate upon light irradiation.32 These properties 
may be especially useful in the delivery of cytotoxic molecules via conjugation to 
antibody targeting agents, such as those shown in Figure 2.1, that may alter the efficacy 
of the molecule due to the relative size of the antibody.30,33 Upon delivery and 
endocytosis to the cell, the small molecule could be photocleaved to remove the 
potentially inactivating steric bulk of the antibody allowing it to achieve its full activity. 
A purely photocleaving UAA without the capacity for bioconjugation has previously 
been developed and utilized to cleave the protein backbone upon light exposure.34 Our 
envisioned UAA expands upon this feature to introduce a handle for a bioorthogonal 
conjugation reaction. 
Results and Discussion 
Toward this goal a novel UAA was developed containing both a dimethoxy-
ortho-nitrobenzyl functionality for photoreactivity, and an alkynyl moiety for 
conjugation.  
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The UAA (1) can be synthetically accessed beginning from commercially 
available vanillin (2) in a concise six-step sequence (Figure 1). Vanillin was first 
propargylated to form 3 in order to provide the alkyne functionality for future 
bioconjugation.  
Scheme	2.1:	Synthesis	of	a	caged	tyrosine	 amino	acid	possessing	a	
bioorthogonal	 handle		
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The nitro group was then installed using nitric acid to afford 4 in moderate yield and high 
regioselectivity.  
 
The aldehyde 4 was then reduced with sodium borohydride in 1 M NaOH to afford the 
alcohol 5 in 71% yield. Interestingly, reactions in ethanol, a more conventional solvent 
for this type of reduction, resulted in substantially lower yields even when used in large 
excess, necessitating the reduction in aqueous sodium hydroxide.  
 
The alcohol 5 was then brominated with PBr3 to provide 6, which was then alkylated with 
diethyl acetamidomalonate to yield the protected UAA 7. 
O
MeO
O
H
NO2 O
MeO
NO2
O-
BH3-H H
H
H O H
O
MeO
NO2
OH
Scheme	2.4:	Reduction	of	aldehyde	to	alcohol
H
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Scheme	2.2:	Propargylation of	Vanillin
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Scheme	2.3:	Addition	of	a	nitro	group	to	3-methoxy-4-(prop-2-yn-1-yloxy)benzaldehyde
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 Several conditions were examined for the conversion of 6 to 7; however, the most 
efficacious reaction progressed under microwave irradiation.35 Once optimized, 7 was 
deprotected in 6 N HCl under microwave irradiation to yield the desired UAA in an 
overall yield of 19%. The purity and identity of 1 was confirmed by both NMR and 
GC/MS analyses. 
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OH PBr2
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MeO
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Scheme	2.5:	Bromination of	(5-methoxy-2-nitro-4-(prop-2-yn-1-yloxy)phenyl)methanol	
Scheme	2.6:	Addition	of	protecting	group	to	1-(bromomethyl)-5-methoxy-2-nitro-4-(prop-2-yn-1-yloxy)benzene	
H
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A later attempt to make this product corroborated the ease of the synthesis, until 
purification of 1 after deprotection proved to be very difficult. Purification by flash 
chromatography in a gradient of DCM to 10% MeOH in DCM did not result in high 
purity of product. Further purification of product obtained from flash chromatography 
through the use of a silica plug still did not remove the undesirable material from the 
product. Using celite as a filtering agent also did not help to increase purity of the 
product. After many unsuccessful attempts, a new deprotection method was tested. The 
reaction was heated in an oil bath overnight at 60oC before increasing to 90oC for 4 
hours. The reaction was quenched with dI H2O, extracted with EtOAc, and the aqueous 
layer was concentrated by rotary evaporation. A cursory NMR of this product revealed an 
incomplete deprotection, so the sample was subjected to another deprotection run 
overnight at 90oC, after which the sample was extracted with ether (3x 2 mL). The 
aqueous layer was again concentrated by rotary evaporation. Finally, the product could be 
confirmed by NMR. 
With the desired UAA in hand, it was necessary to elucidate an appropriate aaRS 
that could recognize and effectively incorporate 1 into a protein. Typically, a double-
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sieve selection on an aaRS library is required to identify a functional aaRS; however, 
recent reports have found several existing aaRSs that displayed non-specific 
incorporation toward additional UAAs.36,37 We hoped to exploit this promiscuity to 
obviate the necessity of an aaRS selection, and thus initiated a screen with several 
existing synthetases for the incorporation of 1 using a GFP reporter (sfGFP; super-folding 
green fluorescent protein). The ability to incorporate the UAA would result in a 
fluorescent signal due to the production of functional GFP, whereas a failure to 
incorporate results in a non-fluorescent truncated protein due to the inability to suppress 
the TAG stop codon. Thus, increased fluorescence could be correlated to aaRS 
promiscuity toward 1. A range of aaRSs were selected including Bipy, pCNF, ONBY, 
and NapA due to either their previously reported promiscuity, their large UAA binding 
pocket, or their ability to incorporate structurally similar UAAs. Upon screening 
the pCNF aaRS, a significant increase in fluorescence in the presence of 1 relative to the 
absence was observed. Consequently, the pCNF-aaRS was selected for expression of 1.  
To confirm incorporation, E.coli cells harboring a plasmid that encodes the 
aaRS/tRNA pair and a plasmid encoding GFP with a TAG mutation at surface exposed 
residue 151 were induced with IPTG/Arabinose in the presence of 1, and incubated 16 h 
at 30 °C. The cells were then lysed and GFP was purified using a commercially available 
Ni–NTA resin and analyzed via SDS–PAGE and fluorescence. Based on both 
fluorescence data and gel analysis, 1 is incorporated into GFP at 68% relative to wild 
type GFP expression. Incorporation of 1 into ubiquitin was also attempted, but generated 
no promising results after multiple attempts.  
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Following expression and purification of the GFP containing 1, a proof-of-
concept experiment was performed to ascertain the feasibility of both the bioconjugation 
and the photoreactivity of the UAA. Our laboratory recently reported a Glaser–Hay 
bioconjugation involving the coupling of terminal alkynes.26,38 Consequently, this novel 
bioconjugation was employed with the new UAA based on the alkynyl handle 1. The 
mutant GFP was reacted with an alkyne containing Alexafluor-488 molecule in the 
presence of CuI/TMEDA for 4 h at 4 °C. The reaction was then purified by size-
exclusion centrifugation and the protein was denatured to eliminate protein-derived 
fluorescence. The conjugation was then analyzed by SDS–PAGE (Figure 2.2).  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure	2.2:	SDS-PAGE	analysis	of	the	Glaser-Hay	bioconjugation	
reaction	and	the	photoregulation of	the	conjugate.	The	top	panel	
shows	presence	of	protein	as	stained	with	Coomassie	Brilliant	Blue.	
The	lower	panel	shows	presence	or	absence	of	fluorescence.	Lane	1:	
Ladder;	Lane	2:GFP	containing	1 not	subjected	to	Glaser-Hay	
conditions;	Lane	3:	GFP	containing	1 coupled	with	AlexaFluor-488	
alkyne,	but	not	irradiated	with	UV;	 Lane	4:	GFP	containing	1 coupled	
with	AlexaFluor-488	alkyne,	irradiated	with	365	nm;	Lane	5:	Wild-type	
GFP	not	irradiated;	Lane	6:	Wild-type	GFP	irradiated	at	365	nm
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As indicated on the gel, a successful conjugation was observed only in the 
presence of CuI, alkynyl-fluorophore, and TMEDA, further confirming the presence 
of 1 within the protein as the alkynyl functionality is required for a productive Glaser–
Hay reaction to occur. Based on gel analysis, and absorbance measurements, the 
conjugation progressed almost to completion with a 93% conversion. 
Upon demonstration of successful conjugation, the photolability of the UAA was 
assessed. Due to the mechanism of decaging (Scheme 2.8), the UAA should sever the 
peptide backbone at the site of incorporation leading to a fragmented protein upon 
irradiation.34 
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In order to probe the functionality of the caged amino acid, the previously 
prepared GFP-Alexafluor 488 conjugate was incubated in the presence and absence of 
non-cytotoxic UV irradiation at 365 nm for 10 minutes, 20 minutes, or 30 minutes, with 
30 minutes yielding the most promising results. The reactions were then visualized by 
SDS–PAGE to ascertain the ability of the UAA to perturb the GFP backbone. 
Unfortunately, a definitive cleavage was not observed; however, protein degradation was 
unequivocally observed after 30 min of irradiation at 365 nm. This result suggests that 
the cleavage of the backbone did occur; however, under these conditions additional 
protein degradation then occurred. No reaction was observed in the conjugate that was 
not irradiated, or in wild-type GFP (not containing 1), suggesting that the protein 
degradation is directly due to the presence of the UAA and not simply due to UV 
irradiation. While some minor effect of irradiation on wild-type protein may have 
occurred, repeating the experiment with either 20 min or 30 min of irradiation on ice 
resolved the loss of wild-type, while still degrading protein containing 1. We hypothesize 
that the global degradation may be the result of protein instability upon cleavage. While 
this observed nonspecific degradation is not ideal, the decomposition would only be 
triggered after the selective uptake of the protein-small molecule conjugate into the target 
cell. Successful delivery of the cargo is therefore independent of a clean photocleaved 
protein.  
Ultimately, the synthesis, incorporation, conjugation, and photoreaction 
of 1 represent a useful example for the implementation of UAAs within the context of a 
protein. Ideally, this work can be continued to utilize 1 in a more practically relevant 
protein (e.g. antibody), and probe its use in bacterial cell culture. This unique UAA 
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represents a mechanism to both prepare and release bioconjugates and possesses a wide 
range of potential both in therapeutic and biomaterial applications. 
Experimental 
General:  Solvents and reagents were obtained from either Sigma Aldrich or Fischer 
Scientific and used without further purification. Reactions were performed in ambient 
conditions with non-distilled solvents. Microwave reactions were performed using a 
CEM Discovery microwave. NMR data was acquired on a Varian Gemini 400 MHz 
NMR. All GFP proteins were purified using a Qiagen Ni-NTA Quik Spin Kit, according 
to manufacturer’s protocols. Photocaging deprotection was performed using a VWR UV-
AC hand lamp.  
3-Methoxy-4-(prop-2-yn-1-yloxy)benzaldehyde (3): The synthesis was performed 
according to literature conditions.39 Vanillin (1 eq., 1.5 g, 9.86 mmol) was added to a 
flame-dried round bottom flask with Cs2CO3 (1 eq., 3.213 g, 9.86 mmol) and dry DMF 
(25 mL). The reaction was stirred for five minutes at room temperature before addition of 
propargyl bromide (5 eq., 3.742 mL, 49.3 mmol). The reaction was allowed to stir for 24 
hours. The reaction was quenched with dI H2O (30 mL) and extracted with EtOAc (3x30 
mL) then back extracted with brine (3x80 mL). The EtOAc layer was dried with 
anhydrous Mg2SO4, gravity filtered, and concentrated by rotary evaporation. The 
resulting products were purified by flash chromatography (5:1 Hexanes: EtOAc), 
resulting in a white crystalline solid (1.16 g, 6.10 mmol, 62% yield). 
5-methoxy-2-nitro-4-(prop-2-yn-1-yloxy)benzaldehyde (4): To an aluminum foil 
wrapped round bottom flask was added 3 (1.16 g, 6.10 mmol, 62% yield). In a separate 
flask, 50 mL HNO3 was allowed to incubate on ice until chilled. 50 mL HNO3 was added 
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to the round bottom containing 3, and allowed to stir for 30 minutes at 0oC. The reaction 
was then stirred at room temperature for five hours before being quenched with chilled dI 
H2O (200 mL). The yellow precipitate was collected by vacuum filtration (1.759 g, 7.48 
mmol, 93.8% yield). The product required no further purification. 1H NMR (400MHz; 
CDCl3): ∂ 10.45 (s, 1H), 7.79 (s, 1H), 7.43 (s, 1H), 4.90 (s, 2H), 4.02 (s, 3H), 2.62 (s, 
1H); 13C NMR (400MHz; CDCl3): ∂ 187.9, 153.9, 146.7, 140.2, 126.6, 110.5, 109.6, 
78.0, 76.5, 57.4, 57.0. 
(5-Methoxy-2-nitro-4-(prop-2-yn-1-yloxy)phenyl)methanol (5): Product 4 (1 eq., 
1.759 g, 7.48 mmol) was dissolved in EtOH (120 mL) in an aluminum foil wrapped 
round bottom flask. In a separate flask, NaBH4 (3 eq., 0.847 g, 22.4 mmol) was dissolved 
in NaOH (50 mL, 1 M). The NaBH4 solution was then added to the flask containing 4 
and EtOH. The reaction was then allowed to stir at room temperature for 16 hours. The 
reaction was neutralized using HCl (4 mL, 12 M), then extracted with EtOAC (3x30mL) 
and back extracted with brine (3x80mL). The EtOAc layer was dried with anhydrous 
Mg2SO4 and concentrated with a rotary evaporator. The product was obtained as a pale 
yellow solid (0.721 g, 3.04 mmol, 40.6% yield). 1H NMR (400MHz; CDCl3): ∂ 7.89 (s, 
1H), 7.22 (s, 1H), 4.98 (s, 2H), 4.84 (s, 2H), 4.01 (s, 3H), 2.58 (s, 1H), 1.56 (s, 1H); 13C 
NMR (400MHz; CDCl3): ∂ 153.9, 146.7, 140.22, 126.6, 111.1, 78.0, 76.5, 63.0, 57.3, 
29.9. 
1-(Bromomethyl)-5-methoxy-2-nitro-4-(prop-2-yn-1-yloxy)benzene (6): Product 5 (1 
eq., 0.721g, 3.04 mmol) was added to a round bottom flask wrapped in aluminum foil. 
DCM (40 mL) and PBr3 (2.42 eq., 0.700 mL, 7.37 mmol) were added and the reaction 
was allowed to stir for 24 hours at 0oC. The reaction was quenched with dI H2O (15 mL), 
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then extracted with EtOAc (3x30 mL) and back extracted with brine (3x80 mL). The 
EtOAc layer was dried with anhydrous Mg2SO4. The product was concentrated by rotary 
evaporation before purification by flash chromatography (gradient of 3:1 Hexanes:EtOAc 
to 1:1 Hexanes to EtOAc), resulting in a yellow solid (0.600 g, 2.00 mmol, 65.8% yield). 
1H NMR (400MHz; CDCl3): ∂ 7.85 (s, 1H), 6.98 (s, 1H), 4.87 (s, 2H), 4.84 (s, 2H), 4.01 
(s, 3H), 2.60 (s, 1H), 13C NMR (400MHz; CDCl3): ∂ 153.9, 146.7, 140.2, 128.7, 114.3, 
111.3, 57.2, 56.8, 29.9. 
Diethyl-2-acetamido-2-(5-methoxy-2-nitro-4-(prop-2-yn-1-yloxy)benzyl)malonate 
(7): Diethyl acetamidomalonate (2 eq., 0.145 g, 0.67 mmol) and Cs2CO3 (1 eq., 0.109 g, 
0.33 mmol) were added to acetonitrile (1 mL) in a microwave vial and allowed to stir for 
five minutes at room temperature. Product 6 was dissolved in acetonitrile (2 mL), then 
added to the microwave vial. The reaction was subjected to microwave irradiation in 
standard mode (10 min, 130oC, 300W) then quenched with dI H2O (5 mL). The reaction 
was extracted with EtOAc (3x30 mL) and back extracted with brine (3x80 mL). The 
EtOAc was dried with Mg2SO4 then concentrated using rotary evaporation, resulting in a 
brown oil. The reaction was then purified using flash chromatography (1:1 hexanes: 
EtOAc), and yielded a brown solid ( 0.235 g, 0.54 mmol, 27.0% yield). 1H NMR 
(400MHz; CDCl3): ∂ 7.69 (s, 1H), 6.76 (s, 1H), 6.52 (s, 1H), 4.80 (s, 2H), 4.33-4.13 (m, 
4H), 4.10 (s, 3H), 3.90 (s, 2H), 2.59 (s, 1H), 1.94 (s, 3H), 1.29 (t, J = 7.2, 6H); 13C NMR 
(400MHz; CDCl3): ∂ 169.7, 167.8, 152.9, 145.7, 142.1, 126.1, 116.0, 115.9, 78.0, 76.6, 
66.1, 63.0, 57.1, 56.5, 35.2, 14.0, 14.0. 
1-Carboxy-2-(5-methoxy-2-nitro-4-(prop-2-yn-1-yloxy)phenyl)ethan-1-aminium (1): 
Compound 7 (1 eq., 0.133 g, 0.30 mmol) was allowed to stir with 6M HCl (3 mL) for 16 
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hours at 90oC. The reaction was extracted with EtOAc (2x3mL), then extracted with 
diethyl ether (2x3 mL). The aqueous layer was then concentrated by rotary evaporation. 
1H NMR (400MHz; CDCl3): ∂7.88 (s, 1H), 7.11 (s, 1H), 4.86 (d, J=6, 2H), 4.38-4.31 (m, 
1H), 3.78 (s, 3H), 3.76-3.70 (m, 1H), 3.43-3.33 (m, 1H), 3.05 (s, 1H); 13C NMR (400 
MHZ; CD3OD): δ 169.8, 168.3, 152.4, 146.3, 141.5, 122.9, 114.9, 112.1, 76.4, 56.1, 53.1, 
39.7, 34.1 
 
1H NMR for product 1: 
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Expression of GFP and aaRS assessment. A pET-GFP-TAG 151 plasmid (0.5 µL) was 
co-transformed with a pEVOL-pCNF plasmid (0.5 µL) in Escherichia coli BL21(DE3) 
cells utilizing an Eppendorf eporator electroporator. The cells were then plated and 
grown on LB agar in the presence of chloramphenicol (34 mg/mL) and ampicillin (50 
mg/mL) at 37° C overnight. One colony was used to inoculate LB media (4 mL) that 
contained ampicillin (4 µL, 50 mg/mL) and chloramphenicol (4 µL, 34 mg/mL). The 
culture was incubated at 37° C for 5 hours. An expression culture was created containing 
LB media (10 mL), ampicillin (10 µL, 50 mg/mL), and chloramphenicol (10 µL, 34 
mg/mL), and then was inoculated with the previous culture (700µL). The expression 
cultures were incubated at 37° C to an OD600 between 0.06 and 0.08 at 600 nm, and 
protein expression was induced by addition of propargyl tyrosine (100 µL, 100 mM),  
20% arabinose (10 µL), and 0.8 mM isopropyl β-D-1-thiogalactopyranoside (IPTG;  
10 µL). The cultures were allowed to shake at 30 ̊ C for 16 h then centrifuged at 5,000 
rpm for 10 minutes, and stored at -80 ̊ C for 30 min. The cell pellet was re-suspended 
using 500 µL of Bugbuster (Novagen) containing lysozyme, and incubated at 37 ̊ C for 
20 minutes. The solution was transferred to an eppendorf tube and centrifuged at 15,000 
rpm for 10 minutes, then the supernatant was poured into an equilibrated His-pur Ni-
NTA spin (Qiagen) column with nickel resin (200 µL), and GFP was purified according 
to manufacturer’s protocol. Purified GFP was analyzed by SDS-PAGE (BioRad 10 % 
precast gels, 150 V, 1.5 h), and employed without further purification. 
The aaRSs were assessed for unnatural amino acid incorporation by first co-
transforming pET-GFP-TAG 151 plasmids (0.5 µL) with Bipy, Nap, ONBY, and pCNF 
pEVOL plasmids (0.5 µL), and plated in the same method as described above. For each 
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pEVOL plasmid, one colony was used to inoculate LB media (4 mL) in separate 
containers that contained ampicillin (4 µL, 50 mg/mL) and chloramphenicol (4 µL, 34 
mg/mL). The cultures were incubated at 37° C for 5 hours. Expression cultures were 
created containing LB media (4 mL), ampicillin (4 µL, 50 mg/mL), and chloramphenicol 
(4 µL, 34 mg/mL), and then were inoculated with the previous culture (250 µL). The 
expression cultures were incubated at 37° C to an OD600 between 0.06 and 0.08 at 600 
nm. Protein expression was induced by addition of 20 % arabinose (4 µL), and 0.8 mM 
IPTG (4 µL). The cultures were then plated on a 96-well plate (200 µL), with six wells 
for each plasmid. Three wells were designated as controls, and the other three were 
designated for the experiment. Propargyl tyrosine UAA (100 µL, 100 mM) was added to 
the experimental wells only. The plate was allowed to shake at 30° C for 16 h, after 
which it was measured for fluorescence (528 nm and 485 nm) utilizing a Synergy HT 
microplate reader. 
Glaser-Hay Bioconjugation. GFP containing 1 at residue 151 (20 µL), AlexaFluor-488 
Alkyne (15 µL, 1 mM), CuI (5 µL, 50mM), and tetramethylethylenediamine (5 µL, 
50mM) were added to an eppendorf tube. A control reaction omitting the CuI and 
TMEDA was conducted simultaneously. The tubes were incubated at 4 °C for 4 hours. In 
order to remove excess Cu and fluorophore, a buffer exchange was performed with Spin-
X UF concentrator columns, and with PBS (8x200 µL) to a final volume of 50 µL.  
Decaging of GFP was achieved by firstly placing the above GFP containing 1 
Glaser-Hay (15 µL) into a clear eppendorf tube. A control was made by adding GFP wild 
type (15 µL) to a clear Eppendorf tube. The tubes were irradiated at 365 nm for 30 mins 
on ice using a VWR UV-AC hand lamp. The GFP was analyzed by SDS-PAGE (BioRad 
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10 % precast gels, 150 V, 1.5 h). Gels were imaged by using a BioRad Molecular Imager. 
A spyro ruby scan was conducted first to analyze fluorescence. The gel was then stained 
using Coomassie Brilliant Blue for one hour, and destained using destain solution (60% 
dI H2O, 30% MeOH, 10% acetic acid) until the gel was clear. The gel was then imaged 
using the Coomassie protocol on the gel imager.  
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Chapter 3: Development of a Copper-Free Microwave 
Mediated 1,3-Dipolar Cycloaddition 
Since its discovery in 2002, 
the copper-catalyzed azide-alkyne 
cycloaddition (CuAAC) has 
become an indispensable tool for chemists. The CuAAC reaction, developed 
independently by Sharpless and Meldal, can be used to link an azide and an alkyne to 
form a 1,2,3-triazole ring in a quick single step (Figure 3.1).40 If both the azide and 
alkyne are part of larger molecules, the triazole forms as a 1,4 regioisomer.40  
 
 
R + N3 R' N NN
R'
R
H
Cu(II)
TCEP
Figure	3.1:	General	CuAAC reaction
Scheme	3.1:	CuAACmechanism	41
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This is in direct contrast to the previously developed Huisgen cycloaddition, a 
copper-free azide alkyne cycloaddition, that yields a mixture of 1,4- and 1,5- 
regioisomers at a much slower rate.42  
 
 
 
 
 
Especially interesting to synthetic chemists is the ability of this reaction to 
perform asymmetric reactions yielding chiral products in a single step, while biochemists 
admire this reaction for its ability to be performed in an aqueous solvent.40,42 The robust 
nature of this reaction has allowed for it to quickly incorporate into fields such as drug 
design, sensing, catalysis, peptide conjugation, and bioconjugation.40,44 
  Microwave irradiation can be a very powerful tool in organic synthesis that 
affords some unique advantages. Interestingly, the use of microwave irradiation in 
chemistry began in 1986 with the use of household 
microwave ovens.46 In the 1990s, microwave 
instrumentation for chemical research was 
developed, helping to put an end to the hazards 
that came with performing chemical reactions in a 
domestic microwave oven.46 As the beneficial 
effects of utilizing microwave irradiation became 
RNN
+
-N
R'
H N N
NR
R'
+ N N
NR
R'
Scheme	3.2:	Copper-free	Huisgen cycloaddition	mechanism	43
Figure	3.2:	CEM	microwave	showing	applied	microwave	
irradiation45
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clearer, work involving microwaves expanded, and as an energy saving and inexpensive 
method, utilizing microwave irradiation helped decrease the environmental impact of 
performing reactions. In addition to lessening the impact that chemistry can have on the 
environment, microwaves are beneficial to the scientist, as they can increase the rate of 
reaction and play a role in the selectivity, all while increasing purity of the reaction 
product.46,47 These unique advantages have allowed microwave irradiation to be applied 
to many different reactions, including C-H bond activation, carbonylation reactions, and 
Suzuki couplings.46,48  
 Copper free azide-alkyne cycloadditions have been previously reported. In 
addition to the Huisgen cycloaddition, the reaction can be coaxed by introducing a highly 
strained molecule as a starting material, such as a benzocyclononyne or a cyclooctyne.49 
This method is aptly named the strain promoted azide alkyne cycloaddition.49 Though 
these starting materials are unusual, the removal of copper is an exceptional way to 
expound upon the biological applications of the reaction. Under copper catalyzed 
conditions, the production of radical oxygen species by copper(II) substances can lead to 
protein degradation and phospholipid peroxidation.50,51 Additionally, copper (II) can be 
reduced by superoxide anions found in the body to copper(I), which can stimulate the 
homolysis of hydrogen peroxide to form the extremely deleterious hydroxyl free 
radical.51 Obviously this is not ideal for in vivo reactions or even for biological 
applications. Excess copper introduced into a biological system can wreak havoc on 
healthy cells. In order to combat this, syntheses that do not utilize copper are necessary to 
ensure a completely copper-free product. 
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Results and Discussion 
 Attempts at a copper-free, microwave mediated 1,3-dipolar cycloaddition initially 
required many trials in order to optimize reaction conditions. Microwave times, 
temperatures, and reaction settings were varied in addition to variation in purification 
techniques. Preliminary reactions were performed using benzyl azide (1 eq) and 
phenylacetylene (1 eq) in addition to equal parts deionized water and tert-butanol. Tris(2-
carboxyethyl)phosphine (50 mM, 32µL) was added as a reducing agent, but the 
characteristic copper(II) catalyst employed in 1,3-dipolar cycloaddition reactions was 
omitted.  
 
 During purification of the initial reactions, an extraction was performed using 
ethyl acetate and brine in order to remove potential contaminants from the reaction 
mixture. However, it was hypothesized that the miscibility of tert-butanol in water could 
lead to a reduction of product in the ethyl acetate layer, resulting in low yields. An 
experiment using dichloromethane as the organic solvent resulted in similar yields, 
leading to a reassessment of possible purification techniques. Eventually it was decided 
that removal of excess solvent from the reaction would be performed using rotary 
evaporation immediately after the reaction was removed from the microwave and 
quenched with deionized water. After removal of solvent, the reaction would undergo 
Scheme	3.3:	Reaction	of	benzyl	azide	with	phenyl	acetylene	
N3 +
N N
N
TCEP; H2O, tBuOH
Microwave: SPS 300W, 20 min, 168oC
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purification by flash chromatography to isolate the product. Adaptation of this method 
resulted in higher yields of the product and was therefore employed for all further 
reactions.  
 Subsequently, microwave irradiation conditions were examined in order to 
determine which facilitated the highest yield. Microwave irradiation of 100W, at 100oC, 
for 10 minutes was used as a starting point, but generated a poor yield of 21.9%. The 
same reaction was performed in a 100oC oil bath and afforded a less than 5% yield, 
showing that microwave irradiation does confer some level of advantage and was 
therefore used for all following reactions. Next, the temperature of the microwave was 
raised to 125oC, keeping power and time the same. The reaction resulted in only a 
slightly higher yield of 26.0%. Increasing reaction time to 20 minutes, still at 100W and 
125oC, afforded a slightly higher yield of 31.4%. These results encouraged another 
increase in temperature and time, to 30 minutes; however reactions under those 
conditions did not increase yield significantly.  
 In order to further optimize the reaction, other microwave settings were analyzed, 
beginning with the power mode setting. This setting allows constant power to be 
delivered to the reaction until the reaction mixture reaches a preset temperature, at which 
point the power is turned off. If the reaction mixture reaches the preset temperature 
before the set time has completed, the power will still turn off and will not be reapplied 
even after the reaction has cooled below the pre-set temperature. The pre-set temperature 
in this experiment was 168oC, leading to reaction times less than 10 minutes depending 
on how long the reaction mixture took to reach 168oC. At 100W, the experiment ran for 
approximately 10 minutes, and resulted in a 23.0% yield. At 200W, the reaction ran for 
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about 2 minutes and resulted in a 26.0% yield. Increasing the power to 300W lead to a 
large increase in yield (49.2%), even though the reaction only proceeded for 
approximately 1 minute. In an attempt to increase the yield further, the reaction was 
subjected to a second 300W irradiation. Interestingly, this lowered the yield to 21.9% 
suggesting that reaction conditions may be too harsh, leading to a decomposition of either 
reagents or product.  
With promising results in hand, another microwave setting was examined. The 
peptide synthesis (SPS) setting provided unique settings that could be used to overcome 
the pitfalls of the power mode setting. Like power mode, SPS mode allows for a high 
temperature to be pre-set so that when the reaction mixture reaches that temperature the 
power is shut off. However, SPS mode allows for the ability to reapply power once the 
reaction has decreased below a different, preset temperature. The high temperature for 
these experiments was set at 168oC with a ΔT of 15oC, meaning that once the reaction 
mixture dropped below 153oC, power was reapplied to the reaction until it reached 168oC 
again. The reactions were tested at 200W and 300W for 20 minutes, yielding a 48.1% 
yield and an impressive 96.2% yield, respectively. When comparing the SPS mode 300W 
copper-free reaction with a reaction performed under the same conditions and containing 
copper, similar yields were observed, leading to conclusions that the use of microwave 
irradiation is a viable alternative to a copper catalyst. With optimized reaction conditions 
determined, an array of alkynes and azides were reacted in order to examine the breadth 
of the reaction (Table 3.2).  
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Power (W) Time	(min) Temperature	
(OC)
Setting Yield
100	 10 100 Standard 21.9%
100 10 125 Standard 26.0%
100 20 125 Standard 31.4%
100 10 168 Power 23.0%
200 2 168 Power 26.0%
300 1 168 Power 49.2%
300 2 168 Power 21.9%
200 20 168	(!T=15) SPS 48.1%
300 20 168	(!T=15) SPS 96.2%
Table	3.1:	Optimization	of	microwave	copper-free	azide	alkyne	cycloaddition	reaction	utilizing	benzyl	
azide	and	phenylacetylene	
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Table	3.2:	Copper-free	azide	and	alkyne	cycloaddition	reactions	and	their	
respective	yields 
	
	
42 
Long hydrocarbon chain azides resulted in decreased yields, irrespective of the 
characteristics of the alkynes used. This may be a result of the long hydrocarbon chains 
not being miscible with the water and tert-butanol solvents, or that the molecules possess 
minimized dipoles and therefore are not as susceptible to microwave irradiation in order 
to facilitate the reaction.  
In order to test these theories, we tested alkynes with long hydrocarbon chains to 
see if similar results were observed. Toward this end, 1-hexyne was chosen as a 
corresponding alkyne, and reacted with benzyl azide and trimethylsilyl azide. 
Interestingly, these reactions yielded 96.8% and 37.6%, respectively. Higher yields of 
these reactions sparked new hypotheses, the most convincing is that the aliphatic azide is 
less stable under microwave irradiation and therefore more likely to degrade, decreasing 
overall yield. Though a realistic hypothesis, this premise needs further testing before any 
definitive conclusions can be made.  
 Intriguingly, polar alkynes also produced unfavorable yields when reacted with 
azides of differing characteristics. Upon reaction with benzyl azide, azidoheptane, and 
trimethylsilyl azide, propargyl alcohol produced yields of less than 5% for all reactions. 
In order to help combat this low reactivity, propargyl alcohol was protected using trityl 
chloride (Figure 3.2). Once protected, yields were increased significantly, supporting a 
hypothesis that alkynes possessing more non-polar moieties are necessary to increase 
yields of the reaction.  
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To attempt further optimization of yields for reactions with trityl chloride 
protected propargyl alcohol (((prop-2-yn-1-yloxy)methanetriyl)tribenzene, 21), the 
reaction time was increased from 20 minutes to 60 minutes in SPS mode, 300W, 168oC, 
ΔT=15oC. It was hypothesized that lower yields for the trityl chloride protected propargyl 
alcohol arose from steric bulk, and longer reaction times might allow more molecules to 
align in a sterically favorable manner for reaction. The reaction was first tested with 
benzyl azide, giving an increase in yield of 18%. An identical method was then applied to 
reactions of trityl chloride protected propargyl alcohol with azido heptane and 
trimethylsilyl azide, yielding no significant increase in yield. These results suggest that 
steric hindrance only plays a role in the reaction of benzyl azide with trityl chloride 
protected propargyl alcohol, but that other factors, such as azide stability, must be taken 
into account for low yields after reaction with azidoheptane and trimethylsilyl azide.  
 Interestingly, one of the results of performing a copper-free 1,3-dipolar 
cycloaddition is the mixture of 1,4 and 1,5 regioisomers obtained. When a copper catalyst 
in employed in the reaction, all product is observed as a 1,4 adduct. When omitting 
copper(II), the mixture of regioisomers becomes dependent on the reactants. Reaction of 
1-hexyne with benzyl azide resulted in a 1,4:1,5 adduct ratio of 1:6, but reaction of 1-
hexyne with azidoheptane resulted in a ratio of 1:1.7.  
Cl + OH
TEA O
Scheme	3.4:	Trityl	chloride	protection	of	propargyl	alcohol	
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 Through these reactions it was demonstrated that a microwave mediated, copper 
free 1,3-dipolar cycloaddition reaction can be performed at comparable yields to 
reactions utilizing a copper(II) catalyst. Through an in-depth study of alkyne and azide 
reactants, potential problems were identified and addressed. Further work on this project 
includes a more thorough analysis of steric and electronic effects on the yield of the 
reactions in addition to steric and electronic effects on the mixture of regioisomers 
obtained. Optimization of reaction conditions described should assist in carrying out 
further reactions that have a greater synthetic utility.  
Experimental 
General: Solvents and reagents were obtained from either Sigma Aldrich or Fischer 
Scientific and used without further purification. Reactions were performed in ambient 
conditions with non-distilled solvents. Microwave reactions were performed using a 
CEM Discovery microwave. NMR data was acquired on a Varian Gemini 400 MHz 
NMR.  
General copper-free 1,3-diolar cycloaddition method: To a microwave vial was added 
a small stir bar, an alkyne (1 eq., 0.17 mmol) an azide (1 eq., 0.17 mmol), tris(2-
carboxyethyl)phosphine (TCEP; 50 mM, 32 µL) dI H2O (970 µL), and tert-butyl alcohol 
(tBuOH; 1 mL). The reaction was subjected to microwave irradiation (SPS mode, 20 min, 
0-300 W, 168oC, δT=15oC), then quenched using chilled H2O (10 mL, 0oC). A rotary 
evaporator was used to remove water from the reaction before purification using flash 
chromatography (3:1 hexanes: EtOAc) followed by rotary evaporation to yield the 
product.  
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ppm0123456789
  
N N
N N N
N
1-benzyl-4-phenyl-1H-1,2,3-triazole, 12: The general copper-free 1,3-dipolar 
cycloaddition reaction protocol was followed to give the product as a solid (38 mg, 0.162 
mmol, 96.2% yield). 1H NMR (400 MHz, CDCl3): ∂ 7.80 (dd, J=8.4 Hz, 2H), 7.74 (s, 
1H), 7.66 (s, 1H), 7.45-7.37 (m, 3H), 7.33-7.24 (m, 4H), 7.09-7.06 (m, 2H), 5.58 (s, 2H), 
5.55 (s, 2H); 13C NMR (400 MHz; CDCl3): ∂ 135.4, 133.3, 129.5, 129.2, 128.9, 128.9, 
128.8, 128.8, 128.2, 127.15, 125.7, 119.5, 54.24, 51.80. GCMS (Rt = 12.54) calculated 
for C15H13N3 235.29, found 235.2. Regioisomer ratio of 1,4:1,5 adducts was found to be 
1.1:1. 
1H NMR for product 12: 
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ppm5.56.06.57.07.58.0
  
 
 
 
 
 
 
 
 
 
 
 
1-heptyl-4-phenyl-1H-1,2,3-triazole, 13: The general copper-free 1,3-dipolar 
cycloaddition reaction protocol was followed to give the product as a solid (8 mg, 0.033 
mmol, 19.3% yield). 1H NMR (400 MHz; CDCl3): ∂ 7.83 (dd, J=8.45 Hz, 2H), 7.73 (s, 
1H), 7.69 (s, 1H), 7.50-7.37 (m, 3H), 4.40 (t, 2H), 4.34 (t, 2H), 1.93 (quintet, 2H), 1.82 
(quintet 2H), 1.37-1.17 (m; 8H), 0.90-0.82 (m, 3H); 13C NMR (400 MHz, CDCl3): ∂ 
129.4, 129.0, 128.8, 125.7, 48.29, 31.48, 30.07, 28.52, 26.35, 22.45, 13.96. GCMS (Rt = 
13.77 min) calculated for C15H21N3 243.35, found 243.2. Regioisomer ratio of 1,4:1,5 
adducts was found to be 2:1. 
4-phenyl-1H-1,2,3-triazole, 14: The general copper-free 1,3-dipolar cycloaddition 
reaction protocol was followed to give the product as a solid (16 mg, 0.110 mmol, 64.8% 
yield). 1H NMR (400 MHz; CDCl3): ∂ 7.98 (s, 1H), 7.83 (d, 2H), 7.48-7.37 (m, 3H); 13C 
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NMR (400 MHz; CDCl3): ∂ 129.0, 128.8, 126.1. GCMS (Rt= 8.71 min) calculated for 
C8H7N3 145.16, found 145.1. Regioisomer ratio of 1,4:1,5 adducts was found to be 1:1.2. 
1-benzyl-4-butyl-1H-1,2,3-triazole, 15: The general copper-free 1,3-dipolar 
cycloaddition reaction protocol was followed to give the product as a solid (35 mg, 0.163 
mmol, 96.8% yield). 1H NMR (400 MHz; CDCl3): ∂ 7.94 (s, 1H), 7.41-7.39 (m, 2H), 
7.38-7.26 (m, 3H), 5.56 (s, 2H), 3.09 (t, 2H), 1.77 (q, 2H), 1.00 (3, 2H), 0.91 (q, 3H); 13C 
NMR (400 MHz; CDCl3): ∂ 129.3, 129.2, 128., 125.2, 54.48, 41.40, 17.41, 13.80; GCMS 
(Rt = 11.67 min) calculated for C13H17N3 215.30, found 215.2. Regioisomer ratio of 
1,4:1,5 adducts was found to be 1:6. 
4-butyl-1-heptyl-1H-1,2,3-triazole, 16: The general copper-free 1,3-dipolar 
cycloaddition reaction protocol was followed to give the product as a solid (6 mg, 0.027 
mmol, 15.8% yield). 1H NMR (400 MHz; CDCl3): ∂ 7.73-7.70 (m, 1H), 7.54-7.52 (m, 
1H), 4.30 (t, 2H), 4.24 (t, 2H), 1.72 (quintet, 2H), 1.41-1.260 (m, 14H), 1.00-0.85 (m, 
6H); 13C NMR (400 MHz; CDCl3): ∂ 130.9, 128.8, 65.87, 29.28, 28.92, 28.54, 25.95, 
25.61, 23.74, 22.52, 14.01; GCMS (Rt = 10.49 min) calculated for C13H25N3 223.36, 
found 223.2. Regioisomer ratio of 1,4:1,5 adducts was found to be 1:1.7. 
4-butyl-1H-1,2,3-triazole, 17: The general copper-free 1,3-dipolar cycloaddition 
reaction protocol was followed to give the product as a solid (8 mg, 0.064 mmol, 37.6% 
yield). 1H NMR (400 MHz; CDCl3): ∂ 8.18 (s, 1H), 3.04 (t, 2H), 1.84-1.68 (m, 4H), 1.01 
(t, 2H); GCMS (Rt = 8.78 min) calculated for C6H11N3 125.18, found 125.1. Regioisomer 
ratio of 1,4:1,5 adducts was found to be 3:1. 
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(1-benzyl-1H-1,2,3-triazol-4-yl) methanol, 18: The general copper-free 1,3-dipolar 
cycloaddition reaction was followed; however, low yields of suspected product could not 
be confirmed by 1H NMR or 13C NMR.  
(1-heptyl-1H-1,2,3-triazol-4-yl) methanol, 19: The general copper-free 1,3-dipolar 
cycloaddition reaction was followed, however low yields of suspected product could not 
be confirmed by 1H NMR or 13C NMR.  
(1H-1,2,3-triazol-4-yl) methanol, 20: The general copper-free 1,3-dipolar cycloaddition 
reaction was followed, however low yields of suspected product could not be confirmed 
by 1H NMR or 13C NMR. 
((prop-2-yn-1-yloxy)methanetriyl)tribenzene, 21: Chlorotriphenyl methane (1 eq., 0.50 
g, 1.79 mmol), propargyl alcohol (6.7 eq., 340 µL, 5.86 mmol), triethylamine (TEA; 1.2 
mL) and a stir bar were added to a flame dried vial. The reaction was allowed to stir for 4 
days at room temperature. The reaction was quenched with H2O (30 mL) before 
extraction with EtOAc (3x30 mL) and back extraction with brine (3x80 mL). The EtOAc 
was dried with Mg2SO4, gravity filtered, then concentrated by rotary evaporation to yield 
the product as a yellow powder (417 mg, 1.40 mmol, 78.1% yield). 
1-benzyl-4-(trityloxy)-1H-1,2,3-triazole, 22: To a microwave vial was added a small 
stir bar, ((prop-2-yn-1-yloxy)methanetriyl)tribenzene (21) (1 eq., 50 mg, 0.17 mmol), 
(azidomethyl)benzene (1 eq., 21 µL, 0.17 mmol), tris(2-carboxyethyl)phosphine (TCEP; 
50 mM, 32 µL) dI H2O (970 µL), and tert-butyl alcohol (tBuOH; 1 mL). The reaction 
was subjected to microwave irradiation (SPS mode, 60 min, 0-300 W, 168oC, δT=15oC), 
then concentrated by rotary evaporation before purification by flash chromatography (3:1 
Hexanes:EtOAc) to yield the product as a solid (24 mg, 0.056 mmol, 32.7% yield). 1H 
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NMR (400 MHz; CDCl3): ∂ 7.56 (s, 1H), 7.48 (d, 4H), 7.47-7.18 (m, 16 H), 6.99-6.97 
(m, 4H), 5.52 (s, 2H), 5.50 (s, 2H), 4.31 (s, 2H), 4.08 (s, 2H). 
1-heptyl-4-(trityloxy)-1H-1,2,3-triazole, 23: The general 1,3-dipolar cycloaddition 
reaction protocol was followed to give the product as a solid (8 mg, 0.018 mmol, 10.7% 
yield). 1H NMR (400 MHz; CDCl3): ∂ 7.55 (s, 1H), 7.47-7.44 (m, 5H), 7.35-7.26 (m, 
10H), 4.19 (s, 2H), 4.16 (t, 2H), 1.76 (quintet, 2H), 1.25-1.20 (m, 8H), 0.85 (t, 3H). 
4-(trityloxy)-1H-1,2,3-triazole, 24: The general 1,3-dipolar cycloaddition reaction 
protocol was followed to give the product as a solid (7mg, 0.021 mmol, 12.1% yield). 1H 
NMR (400 MHz; CDCl3): ∂ 7.61 (d, 2H), 7.59 (d, 2H), 7.55 (d, 4H), 7.34-7.23 (m, 10 H), 
3.76 (s, 2H), 3.73 (s, 2H). 
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Chapter 4: Optimization of the Glaser-Hay Reaction in 
a Biological System 
 Copper catalyzed terminal alkyne coupling reactions were first discovered by Carl 
Glaser in 1869 after he noticed that copper(I) phenylacetylide became 
diphenyldiacetylene upon oxidation by air.52 The Glaser coupling reaction became an 
important tool for synthetic chemists looking to form C-C bonds.52 In 1962, the Glaser-
Hay coupling reaction was discovered when Hay added a catalytic amount of N,N,N’,N’-
tetramethylethylenediamine (TMEDA) to the reaction in order to solubilize copper(I) 
halides.52  
 
 
Scheme	4.1:	Glaser-Hay	coupling	mechanism53
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The addition of TMEDA afforded the reaction some unique advantages, including 
the ability for effective coupling under mild reaction conditions.54 As the reaction could 
be effectively done under air and neutral reaction conditions, the next logical step was to 
assess the potential applications in biological chemistry. However, the reaction had only 
been performed in organic solvents. The biological potential for the Glaser-Hay alkyne 
coupling reaction was left untapped until 2015 when Lampkowski and coworkers 
reported a successful Glaser-Hay coupling reaction in an aqueous environment with 
greater than 95% yields, revealing the potential for bioconjugations using this method.26  
 In addition to investigating the efficiency of the Glaser-Hay coupling reaction in 
an aqueous environment, Lampkowski and coworkers explored the utility of this method 
for bioconjugations. By incorporating a terminal alkyne-containing unnatural amino acid, 
such as p-propargyloxyphenylalanine, into GFP, 
researchers were able to assess the effects of Glaser-
Hay reaction conditions on proteins as well as 
assessing the feasibility of using this coupling method 
to generate bioconjugates.26 Researchers were able to 
report success in protein-fluorophore, fluorophore-resin, and protein-resin coupling 
reactions, showing a wide range of usefulness.26 While researchers did report some 
protein degradation due to the production of copper(II) during reaction, it was minimal 
when reaction times were kept below 6 hours.26 High rates of coupling, 71% after 4 hours 
at 4oC and 93% after 6 hours at 4oC, illustrate the effectiveness of this reaction. With 
these favorable results, it is easy to label the aqueous Glaser-Hay coupling as an effective 
+H3N OH
O
O
Figure	4.1:	p-Propargyloxyphenylalanine	UAA
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bioconjugation reaction. Optimization of this method became necessary to ensure highest 
possible yields and most efficient coupling.    
Results and Discussion 
 Optimization of the biological Glaser-Hay reaction began with the expression of 
p-propargyloxyphenylalanine-containing super-folder green fluorescent protein. The 
UAA was incorporated at residue 151, chosen for its position on the outside of the beta 
barrel structure of the protein. This residue allows for the amino acid to be surface 
exposed and able to participate in chemical reactions. All UAA-containing green 
fluorescent protein used in the optimization reactions was purified from the same 
expression culture and analyzed for purity using SDS-PAGE. 
 Initial reactions attempted to reduce the harmful copper(II) formed during the 
reaction in order to reduce protein degradation, a possible source of lowered yields. One 
mechanism to reduce this redox active Cu(II) is the introduction of reducing agents into 
the reaction. Glaser-Hay reactions with reducing agents (50 mM, 2 µL) were performed 
and allowed to run for 4 hours at 4oC, utilizing copper(I) iodide (500 mM, 5µL) as the 
copper catalyst and tetramethylethylenediamine (TMEDA; 500 mM, 5 µL ) as the ligand. 
β-Mercaptoethanol (B-ME), tris(2-carboxyethyl)phosphine (TCEP), dithiothreitol (DTT), 
and nicotinamide adenine dinucleotide (NADH) were chosen for their biological 
compatibility and abilty to be used as reducing agents. Two control reactions were also 
performed, one containing no ligand or copper catalyst, and the other containing ligand 
and copper catalyst, but no reducing agent. After reaction progressed for 4 hours at 4oC, 
the complex was analyzed using SDS-PAGE, and comparison of the ratio of 
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fluorescence: protein was analyzed. Interestingly, no reducing agent was found that could 
yield a higher fluorescence: protein ratio than the reducing agent-free reaction.   
  
(-) Control (+) Control (+) B-ME (+) TCEP (+) DTT (+) NADH
Fluorescence:Protein
Ratio
0.51 2.52 1.23 1.20 0.91 1.40
Table	4.1:	Ratio	of	fluorescence:protein signal	on	SDS-PAGE	for	Glaser-Hay	reactions	utilizing	reducing	
agents,	higher	numbers	indicate	more	protein-fluorophore	coupling		
TMEDA
CuI
sfGFP/p-PrF
AlexaFluor-488	Alkyne
B-mercaptoethanol
TCEP
DTT
NADH - - - - - +
- - - - +											-
- - - +											- -
- - +										- - -
- +										+									+										+									+
- +									+ +										+									+
+												+									+								+										+									+
+												+									+									+									+										+	
Figure	4.2:	SDS-PAGE	performed	on	Glaser-Hay	reactions	utilizing	reducing	agents.	The	
top	panel	shows	fluorescence,	indicating	successful	coupling	between	the	protein	and	
fluorophore.The lower	panel	shows	presence	of	protein	as	stained	with	Coomassie	Brilliant	
Blue.	(1)	Negative	control	reaction,	copper	(I)	iodide	and	TMEDA	omitted	and	no	coupling	
is	observed	(2)	Positive	control,	no	reducing	agent	added	(3)	B-mercaptoethanol added	(4)	
TCEP	added	(5)	DTT	added	(6)	NADH	added		
1 2 3 4 5 6
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In order to approach the problem of degradation due to copper(II) from a different 
angle, the copper source for the reaction was also varied. Traditionally, copper(I) iodide 
is used in the reaction, but changing initial oxidation states of copper and the counter ion 
(I-, Cl-, etc.) could have an effect on overall yield of the reaction. Reactions were 
performed using copper(I) iodide, copper(I) chloride, copper(II) chloride, copper(II) 
sulfate, copper(II) chloride with tris(2-carboxyethyl)phosphine, and copper(II) sulfate 
with tris(2-carboxyethyl)phosphine. Copper catalysts were all added as 5 µL of 500 mM 
solution. Tetramethylethylenediamine (500 mM, 5 µL) was used as the ligand. The tris(2-
carboxyethyl)phosphine was added in addition to copper(II) catalysts to test whether a 
copper(II) catalyst reduced to copper(I) would be advantageous for the reaction. After 
analysis by SDS-PAGE, coupling efficiencies were investigated by comparing the ratios 
of observed fluorescence to observed protein between reactions. Copper(I) iodide yielded 
the highest ratio, suggesting that not only is it imperative to start with copper(I) for the 
Glaser-Hay reaction, but that the iodide counter ion is also beneficial to the reaction in 
some way.  
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(+)Control
Gel 1
Cu(I)Cl Cu(II)Cl2 Cu(II)SO4 (+) Control
Gel 2
Cu(II)Cl2
(+) TCEP
Cu(II)SO4
(+) TCEP
Fluorescence:Protein
Ratio
2.76 0.84 0.76 0.78 2.56 0.15 0.02
Table	4.2:	Ratio	of	fluorescence:protein signal	on	SDS-PAGE	for	Glaser-Hay	reactions	testing	copper	sources,	
higher	numbers	indicate	more	protein-fluorophore	coupling
sfGFP/p-PrF
AlexaFluor-488	Alkyne
TMEDA
CuI
CuCl
CuCl2
CuSO4
TCEP
+												+													+																+														+												+	
+													+													+															+														+												+	
+													- - - - -
- +														- - - -
- - +														- +													-
- - - +															- +	
- - - - +													+	
+												+													+																+														+												+	
2 3 4 5 61
Figure	4.3:	SDS-PAGE	performed	on	Glaser-Hay	reactions	testing	copper	sources.	The	top	
panel	shows	fluorescence,	indicating	successful	coupling	between	the	protein	and	
fluorophore.The lower	panel	shows	presence	of	protein	as	stained	with	Coomassie	Brilliant	
Blue. (1)	Positive	control,	Cu(I)I	used	(2)	Cu(I)Cl	used	(3) Cu(II)Cl2 used,	no	reducing	agent	
added	(4)	Cu(II)SO4 used,	no	reducing	agent	added	(5)	Cu(II)Cl2 used,	TCEP	added	as	a	
reducing	agent	(6)	Cu(II)SO4 used,	TCEP	added	as	a	reducing	agent
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As it was not possible to circumvent the production of copper(II) during the 
reaction, the next step was to assess how to minimize its potential protein degradation. 
Another set of reactions were performed, examining three different radical scavengers. 
Cysteine, oleic acid, and ascorbic acid were added to reactions (500 mM, 5 µL), utilizing 
copper(I) iodide as the copper source and tetramethylethylenediamine as the ligand. After 
reaction time and buffer exchange, the reactions were analyzed by SDS-PAGE to yield 
fluorescence: protein ratios. After accounting for background fluorescence produced by 
some samples, the reaction performed without a radical scavenger yielded the highest 
fluorescence: protein ratio.  
 
TMEDA
CuI
sfGFP/p-PrF
AlexaFluor-488	Alkyne
Cysteine
Oleic	Acid
Ascorbic	Acid - - - +
- - +											-
- +										- -
+												+										+									+								
+													+									+ +								
+												+									+										+								
+												+									+										+								
Figure	4.4:	SDS-PAGE	performed	on	Glaser-Hay	reactions	utilizing	radical	scavengers.	The	
top	panel	shows	fluorescence,	indicating	successful	coupling	between	the	protein	and	
fluorophore.The lower	panel	shows	presence	of	protein	as	stained	with	Coomassie	Brilliant	
Blue. (1)	Positive	control,	no	radical	scavenger	added	(2)	Cysteine	added	(3)	Oleic	acid	
added	(4)	Ascorbic	acid	added
1 2 3 4
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Another reaction parameter that could be adjusted was the ligand associated with 
the copper. In another attempt to increase coupling to the alkyne, 
tetramethylethylenediamine (1) was replaced with six other ligands. The reactions were 
performed without reducing agents or radical scavengers, using copper(I) iodide as the 
copper catalyst. Ethylenediamine (EDA, 2) , N1,N2- dimethylethane-1,2-diamine 
(DMEDA, 3) , N, N, N’, N’-tetrakis(2-hydroxyethyl)ethylenediamine (THEEDA, 4), N, 
N, N’, N’-tetramethyl-
1,3-diaminopropane 
(TMDAP, 5), 2, 2’-
bipyridine (BiPy, 6), 
and N1, N1, N4, N4-
tetramethylbutane-1,4-
diamine (TMBDA, 7) 
were added to separate 
reactions (500 mM, 5 
µL).  
(+)Control (+)Cysteine (+) Oleic
Acid
(+)Ascorbic
Acid
Fluorescence:Protein Ratio 2.56 2.30 1.98 1.01
Table	4.3:	Ratio	of	fluorescence:protein signal	on	SDS-PAGE	for	Glaser-Hay	reactions	
with	radical	scavengers,	higher	numbers	indicate	more	protein-fluorophore	coupling
H2N
NH2
Ethylenediamine
(2)
N
H
H
N
N1,N2- dimethylethane-1,2-
diamine	(3)	
N N
Tetramethylethylenediamine	
(1)
N N
OH
OHHO
HO
N,	N,	N’,	N’-tetrakis(2-hydroxyethyl)ethylenediamine
(4)	
N N
N,	N,	N’,	N’-tetramethyl-1,3-diaminopropane
(5)	
N N
2,2’- bipyridine
(6)
N N
N1,	N1,	N4,	N4-tetramethylbutane-1,4-diamine
(7)	
Figure	4.5:	Ligands	
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After analysis by SDS-PAGE, and accounting for background fluorescence produced by 
the reaction with N, N, N’, N’-tetrakis(2-hydroxyethyl)ethylenediamine, fluorescence: 
protein ratios showed that using tetramethylethylenediamine as the ligand yielded the 
highest fluorescence: protein ratio.  
(+)Control
TMEDA (1)
EDA (2) DMEDA
(3)
THEEDA
(4)
TMDAP (5) BiPy (6) TMBDA (7)
Fluorescence:Protein
Ratio
0.96 0.68 0.74 0.05 0.76 0.79 0.73
Table	4.4:	Ratio	of	fluorescence:protein signal	on	SDS-PAGE	for	Glaser-Hay	reactions	with	
different	ligands,	higher	numbers	 indicate	more	protein-fluorophore	coupling
BiPy (6)
TMBDA	(7)
- - - - - +									-
- - - - - - +	
sfGFP/p-PrF
AlexaFluor-488	Alkyne
TMEDA	(1)
CuI
EDA	(2)
DMEDA	(3)
THEEDA	(4)
TMDAP	(5)
+											+								+										+													+									+										+
+											+								+										+													+										+									+	
+												- - - - - -
- +								- - - - -
- - +												- - - -
- - - +													- - -
- - - - +											- -
+											+								+										+													+									+										+	
2 3 4 5 61
Figure	4.6:	SDS-PAGE	performed	on	Glaser-Hay	reactions	testing	ligands.	The	top	panel	
shows	fluorescence,	indicating	successful	coupling	between	the	protein	and	
fluorophore.The lower	panel	shows	presence	of	protein	as	stained	with	Coomassie	Brilliant	
Blue. (1)	Positive	control,	TMEDA	used	(2)	EDA	used	(3) DMEDA	used	(4)	THEEDA	used	(5)	
TMDAP	used	(6)BiPyused,	(7)	TMBDA	used
7
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In conclusion, no new favorable reactants were found. More exploration of this 
reaction is necessary as only a select few ligands were tested. In addition to testing more 
ligands, new copper sources and radical scavengers can be explored. Time and 
temperature trials will also be beneficial in order to determine if longer a longer reaction 
at a warmer temperature may help to increase coupling between the protein and the 
fluorophore.  
Experimental 
General: Solvents and reagents were obtained from either Sigma Aldrich or Fischer 
Scientific and used without further purification. Reactions were performed in ambient 
conditions with non-distilled solvents. SDS-PAGE gels were imaged on a BioRad 
Molecular Imager (Gel Doc XR+).   
General GFP Expression: A pET-GFP-TAG plasmid (0.5 µL) was co-transformed with 
a pEVOL aminoacyl tRNA synthetase plasmid (0.5 µL) into Escherichia coli BL21 
(DE3) competent cells using an Eppendorf eporator electroporator. The cells were then 
plated (100 µL) on LB agar supplemented with ampicillin (50 mg/mL) and 
chloramphenicol (34 mg/mL). They were incubated 16 hours at 37oC. One colony was 
used to inoculate LB media (10 mL) containing ampicillin and chloramphenicol. The 
culture was shaken overnight at 37oC and used to inoculate an expression culture (250 
mL media, ampicillin 50 mg/mL, chloramphenicol 34 mg/mL) so that the starting OD600 
would be 0.1. The cultures were incubated at 37oC until an OD600 of 0.6-0.8. Protein 
expression was induced by addition of 20% arabinose (250 µL), 0.8 mM isopropyl β-D-
1-thiogalactopyranoside (IPTG; 250 µL), and the unnatural amino acid (2.5 mL, 100 
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mM). Cultures were incubated at 30oC overnight, then pelleted by centrifugation (5,000 
rpm, 10 min). Pellets were stored at -80oC until purification.  
 The cell pellet was resuspended with 500 µL of Bugbuster (Novagen), and 200 
µL of lysis buffer and incubated for 20 minutes at 37oC. Cellular debris was pelleted out 
by centrifugation at 5,000 rpm for 10 minutes and the supernatant was added to an 
equilibrated Ni-NTA resin (200 µL). GFP was purified according to manufacturer’s 
protocol before being analyzed by SDS-PAGE (BioRad 10% precast gels, 150 V, 1.5 
hours). Gels were stained using Coomassie Brilliant Blue, and destained using destain 
solution (60% dI H2O, 30% MeOH, 10% acetic acid). The gel was analyzed using the 
Coomassie protocol on the gel imager. Protein was used without further purification.  
Synthesis of p-propargyloxyphenylalanine: Boc-Tyrosine-OMe (114 mg, 2 eq, 0.385 
mmol) was added to a flame-dried vial. Cesium carbonate (254 mg, 3 eq, 0.578 mmol) 
was then added, followed by dry DMF (3 mL). This mixture was stirred at 100 °C for 20 
mins. 5- Bromo-1-pentyne (20 µL, 1 eq, 0.193 mmol) was then added to the mixture, as 
well as a catalytic potassium iodide. The reaction was stirred overnight at 100 °C, then 
cooled to room temperature and washed with brine (10 mL) and ether (10 mL). The ether 
layer was then washed with brine (10 mL x 3). The brine layer was then back-extracted 
with ether (10 mL). The organic layers were combined, dried with magnesium sulfate, 
filtered, and rotovapped. Column chromotagrophay (silica gel, 5:1 hexanes/ethyl acetate) 
to yield the desired product as a white crystal (22 mg, 0.061 mmol, 31.6% yield). 1H 
NMR (400 MHz, CDCl3): δ 7.02 (d, J = 12 Hz, 2 H), 6.82 (d, J = 12 Hz, 2 H), 4.95 (d, J 
= 8 Hz, 1 H), 4.53 (d, J = 8 Hz, 1 H), 4.03 (t, J = 4 Hz, 2 H), 3.71 (s, 3 H), 3.02 (m, J = 8 
Hz, 1 H), 2.39 (t, J = 4 Hz, 2 H), 1.97 (m, J = 8 Hz, 2 H), 1.55 (s, 1 H), 1.41 (s, 9 H). 13C 
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(400 MHz, CDCl3): δ 172.4, 157.9, 130.3, 127.9, 114.5, 83.5, 79.9, 68.8, 66.0, 54.5, 
52.2, 37.4, 28.3, 28.2, 21.1, 15.1. 
Glaser-Hay Procedure: 30 µL of super-folder GFP (sfGFP; 3.75 mg/mL) from 
expression above was added to an eppendorf tube with AlexaFluor 488 Alkyne (20 µL, 1 
mM), a nitrogenous ligand (0.0025 mmol) and a copper source (0.0025 mmol). Reducing 
agents (1.0x10-4 mmol) and radical scavengers (0.0025 mmol) were tested in some 
reactions, but not added to all reactions. Reactions were exposed to air for 4 hours at 4oC, 
unless otherwise noted. Once completed, excess reactants were removed by buffer 
exchange using Spin-X UF concentrator columns and the reaction was washed with PBS 
(8x200 µL) to a final volume of 50 µL. The reaction was analyzed by SDS-PAGE and 
imaged using a Spyro Ruby scan to analyze fluorescence. The gel was stained using 
Coomassie Brilliant Blue, then destained using a methanol solution (60% dI H2O, 30% 
MeOH, 10% acetic acid). The gel was then analyzed on the gel imager using the 
Coomassie scan.  
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Chapter 5: Fluorescent Labeling of T3 Hormone 
 3,5,3’-Triiodo-L-thyronine (T3, Figure 5.1) is a well studied thyroid hormone that 
functions in development, homeostasis, cellular 
proliferation, cell differentiation, and  gene	 
regulation.55 Interestingly, T3 is even involved in in 
utero development where unusual concentrations of 
T3 hormone can lead to impaired development of somatic tissues necessary for survival 
after birth.56 Intricate study of this hormone, its nuclear receptors, and its mechanisms of 
action are extremely important in learning more about gene regulation and expression. As 
gene overexpression can be a potent cancer trigger, study of these mechanisms can be 
vital in gaining a deeper understanding of some types of cancers. However, in order to 
study the path of T3 into and through the cell, it must be able to be visualized in a non-
invasive manner. Fluorescent imaging has become a useful way to accomplish these 
goals. With three general groups of fluorescent labels, organic fluorophores, fluorescent 
proteins, and quantum dots, a wide range of applications can be explored, such as 
labeling of hormones or labeling of antibodies used for detection of molecules.57,58 
Though each group of fluorescent labels has their own advantages, organic fluorophores 
have an exceptionally wide range of characteristics.d Most possess high molar extinction 
coefficients and can allow for relatively noninvasive coupling to signaling molecules or 
hormones if not coupled to the active region.58 With these considerations in mind, 
fluorescent labeling of T3 hormone with an organic fluorophore was attempted in order to 
visualize its movement into and  through the cell and ultimate binding to its nuclear 
receptor, the thyroid hormone receptor.  
Figure	5.1:	Triiodothyronine (T3)
I
HO
O
I
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O
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Results and Discussion 
 Fluorescent labeling of T3 began with the use of fluorescein isothiocyanate 
(FITC, Figure 5.2) as the fluorescent label, chosen for 
its high molar extinction coefficient and good water 
solubility.58 The reaction proceeded as addition of the 
T3 primary amine to the isothiocyanate group in the 
fluorophore. 
 T3 (1 eq.) was dissolved in dimethylformamide 
(DMF). FITC (1 eq.) was added and the reaction was allowed to stir at room temperature 
for 2 hours. Work-up of the reaction proved difficult. After extraction with EtOAc and 
back extraction with 1M HCl, the organic layer was dried with Mg2SO4. Inspection of the 
Mg2SO4 after drying revealed a bright yellow color, indicative of FITC, that could only 
be removed by rinsing the Mg2SO4 with dichloromethane. A subsequent attempt utilized 
Na2SO4 as a drying agent which proved to yield a much more successful work up.  
 
 
 
 
 
 
OO OH
HO
O
N C S
Figure	5.2:	Fluorescein	isothiocyanate
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The product was then purified by flash chromatography, starting in 3:1 Hexanes: 
EtOAc and increasing in polarity to 100% EtOAc. A yellow product was observed on the 
column that was only removed upon treatment with MeOH. UV active fractions were 
analyzed by NMR; however, due to the small scale of the reaction resulting in low 
amounts of product, no positive identification of the molecule could be made. A later 
reaction was also purified by flash chromatography, using a gradient of 0% MeOH in 
DCM to 20% MeOH in DCM, resulting in a more successful purification attempt. NMR 
was also used to analyze the product of this reaction, but again, the amount of product 
was too low to show any significant signals. 
A third attempt at this reaction utilized the addition of triethylamine (TEA; 20 µL)  
in order to drive the reaction towards completion by the addition of a base. Na2SO4 was 
used as a drying agent, and a 0% MeOH in DCM to 20% MeOH in DCM gradient was 
used during flash chromatography. Instead of NMR, the product of this reaction was 
OO OH
HO
O
N C S
IHO
O
I
H2N OH
O
I
+
OO OH
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O
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HN
O
OH
I
I
O
I
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Scheme	5.1	:	Labeling	of	T3 with	FITC
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analyzed by LCMS. The appearance of a peak at 1040 m/z was used as positive 
identification of a successful coupling between FITC 
and T3. The fluorescently labeled hormone was then 
provided to Dr. Lizabeth Allison for further testing in 
cells.  
Preliminary studies found large overlap between 
the fluorescence spectrum of FITC with other 
fluorophores required in the cell-based assay. Thus, an 
additional fluorophore was utilized to label T3. Reaction of T3 with Fluorescent Red 630 
(Figure 5.4) was performed through nucleophilic attack at the succinimidyl ester by the 
primary amine on T3 to yield the fluorescently tagged molecule as an amide.  
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Figure	5.3:	Fluorescent	Red	630	
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Scheme	5.2:	Fluorescent	labeling	of	T3 with	Fluorescent	Red	630
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Fluorescent red 630 (1 mM, in DMSO) and T3 (1 mM, in dI H2O) were allowed 
to react at 4oC for 16 hours, then concentrated using a centrifugal evaporator. The final 
concentration of T3 after evaporation was 2 mM. T3 labeled with fluorescent red 630 was 
again provided to Dr. Lizabeth Allison for further testing in cells.  
Based on results from the Allison lab, other fluorophores can be examined in an 
effort to facilitate the development of reactions for the fluorescent labeling of the T3 
hormone. Different fluorophores that possess alternative fluorescence spectra can be 
explored, as well as fluorophores that attach to the T3 molecule through different 
linkages. Finally, optimization of the current fluorescent labeling reactions can be 
performed.      
Experimental 
General: Solvents and reagents were obtained from either Sigma Aldrich or Fischer 
Scientific and used without further purification. Fluorophores were obtained from Sigma 
Aldrich. Reactions were performed in ambient conditions with non-distilled solvents. 
Mass spectrum obtained on a Finnigan LCQ Deca ion trap mass spectrometer.  
Labeling of T3 with Fluorescein Isothiocyanate: In a flame dried vial with a stir bar, 
T3 (1 eq., 0.005 g, 0.007 mmol) was dissolved in dimethylformamide (DMF; 2 mL). 
Fluorescein isothiocyanate (FITC; 1 eq., 0.003 g, 0.007 mmol) was added with 
triethylamine (TEA; 20 µL) and the reaction was allowed to stir at room temperature for 
16 hours. The reaction was quenched with dI H2O (2 mL), and extracted with EtOAc 
(3x2 mL), then back extracted with 1M HCl (3x5 mL). The organic layer was dried with 
Na2SO4 before purification by flash chromatography (gradient: 100% dichloromethane to 
20% MeOH in dichloromethane) to yield the product as a yellow solid. (12 mg, 167% 
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yield, yield above 100% due to TEA contamination). MS: expected [M+H+]: 1041.17, 
observed: 1040 m/z.  
Labeling of T3 with Fluorescent Red 630: Fluorescent red 630 (1 mM, 50 µL, in 
DMSO), T3 (1mM, 60 µL, in dI H2O), PBS buffer (10X, 20 µL), dI sterile H2O (70 µL) 
were added to an eppendorf tube and left to react for 16 hours at 4oC. The reaction was 
concentrated using a Thermo Scientific SpeedVac Concentrator.  
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Chapter 6: Selection of an Aminoacyl tRNA Synthetase 
to Incorporate a Photocaged Selenocysteine 
Selenocysteine is commonly recognized as the 21st amino acid.59 It is produced 
selectively in mammalian cells, bacterial cells, and archaeal cells.59 It contains the normal  
amino acid backbone; however, the R group contains one carbon atom bonded to a 
selenium with a hydrogen attached.59 The benefits of incorporating a selenocysteine into 
a protein instead of an analogous cysteine residue is that a selenocysteine residue is more 
reactive than a cysteine residue at physiological pH.59 This is because a selenocysteine 
residue is fully ionized at physiological pH, has a lower redox potential, and has a higher 
nucleophilicity.10,59 Selenium containing compounds can be used as antioxidants and are 
important for control of a cell’s reduction-oxidation reactions.60 Thus the incorporation of 
this functionality into a protein has the potential to advance numerous biological 
reactions, as well as serve as a redox probe. 
 Selenocysteine residues are naturally selectively incorporated into a range of 
proteins. Bacterial cells incorporate it into some formate dehydrogenases which catalyze 
the oxidation of formate into carbon dioxide, and anaerobic 
bacteria incorporate it into some hydrogenases, used to 
catalyze the oxidation of hydrogen.59 Mammalian cells use 
selenocysteine in glutathione peroxidases which protect the 
body from oxidative stress, and also integrate it in 
selenoprotein P, which is secreted in liver and kidney tissues 
as another way to prevent oxidative stress in the body.59  
OH
+H3N
O
Se
O2N
Figure	6.1:	A	photocleavable
selenocysteine	UAA
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 Recently, photocaged selenocysteine (Figure 6.1) has been genetically 
incorporated in yeast cells using green fluorescent protein (GFP) as a biomarker for 
incorporation.10 Upon decaging, greater than 95% of the caged GFP was activated.10 
Pioneering this technique in yeast cells is an important first step, but being able to 
successfully incorporate a caged selenocysteine in bacterial cells will be another key 
stage in developing this technology for a wide range of potential applications. Even 
though selenocysteine residues are naturally incorporated into some proteins, the ability 
to use it to control reactivity of other proteins could be beneficial. It may be considered 
the 21st amino acid, but with genetically encoded incorporation into new proteins its 
reactivity can be harnessed in new ways. 
 Incorporation of a new unnatural amino acid relies on evolution and selection of 
an aminoacyl tRNA synthetase (aaRS) that will not only recognize the tRNA responsible 
for suppression of the TAG stop codon, but that will also recognize the unnatural amino 
acid to be incorporated in that position.61 The selection process starts with a library of 
potential aaRSs with random mutations at distinct resides in the active site.61 The aaRSs 
are first subjected to a round of positive selection in the presence of the desired unnatural 
amino acid. The aaRS that are able to recognize and charge any amino acid present will 
express a chloramphenicol acetyltransferase gene, granting the cell antibiotic resistance 
to chloramphenicol.61 Growth in the presence of chloramphenicol represents expression 
of an aaRS that could potentially recognize and charge the unnatural amino acid to the 
tRNA.61 The aaRSs are then subjected to a negative selection not in the presence of 
unnatural amino acid, but still in the presence of chloramphenicol.61 Those colonies that 
grow during the positive selection, but not during the negative selection are those that 
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charge the unnatural amino acid, but not any of the endogenous amino acids. They are 
subjected to further rounds of selection to increase their selectivity for the unnatural 
amino acid. It is also possible to use the cytotoxic barnase gene as the basis for negative 
selection. By introducing a plasmid containing a barnase gene with three TAG mutations, 
the cells that are able to express the barnase gene in the absence of unnatural amino acid 
are those whose orthogonal aaRS recognize one of the canonical amino acids.62 Those 
cells that then undergo apoptosis are ones that are not selective for the unnatural amino 
acid.62 In this method, chloramphenicol is included in the negative selection conditions.62  
 
 
 
Figure	6.2:	Selection	scheme	62
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Results and Discussion 
 Synthesis of photocaged selenocysteine began with the combination of L-
selenocystine (1 eq.) and nitrobenzyl brominde (4 eq.) in NaOH (0.5 M), EtOH, and 
NaBH4.  
 
 
Addition of the photocaging group necessitated that the reaction flask be wrapped 
in aluminum foil. The reaction was purified by flash chromatography, however high 
levels of MeOH needed to remove the product (50% MeOH in DCM) can result in 
dissolution of silica by MeOH, resulting in yields greater than 100%. Once concentrated 
by rotary evaporation, the product was confirmed by 1H NMR in D2O, resulting in a 
55.5% yield.  
Previous work focused on attempting to incorporate this new UAA using pre-
existing polyselective aaRSs. pEvol synthetases pAcF, ONBY, BipY, pCNF, and AzoF 
were all selected based on their large binding pockets or ability to incorporate a 
structurally similar UAA. Unfortunately, none were found to incorporate the photocaged 
selenocysteine UAA with high reliability or selectivity. Further investigation was 
initiated to elucidate a novel aaRS that could incorporate this new UAA. 
H2N
O O
Se Se
O O
NH2
+ 2
Br
NO2 EtOH, NaOH
NaBH4
2
OH2N
O
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O2N
Scheme	6.1:	Preparation	of	a	photolabile selenocysteine	UAA
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With the amino acid in hand, but no pre-existing aaRSs to allow its incorporation, 
an aaRS selection was attempted to evolve an aaRS capable of recognizing the UAA and 
charging it to a corresponding tRNA.  The first round of positive selection was attempted 
in which the 3D cells were only allowed to incubate for 30 minutes in the presence of the 
UAA (10 mM, 5 µL), but after plating  little growth was observed. The cells that did 
grow on the plate were scraped into LB media, and miniprepped to extract the plasmid 
DNA aaRS library. After purification of DNA, the concentration was checked and found 
to be less than 10 ng/µL for each sample. With such low levels of DNA, it was decided 
that the first round should be re-done in order to ensure optimal levels of DNA.  
 For the second attempt at the first round of selection, the aliquot of 3D library 
added was allowed to shake for 2 hours in the presence of the UAA (10 mM, 5 µL) while 
the rest of the experimental procedure remained the same. There was a large increase in 
cell growth during this attempt, potentially because the 3D cells were allowed a longer 
amount of time to incubate and grow before plating. DNA was extracted from the cells 
and purified on a 1% agarose gel in order to separate the selection plasmid from the 
library plasmid. It was then isolated from the agarose gel, concentrated, and stored at -
80oC.  
 Poor growth of cells plated with the photocaged selenocysteine molecule raise 
questions about the potential toxicity of the molecule. Before another round of selection 
is performed, the toxicity and uptake of the photocaged selenocysteine molecule should 
be tested. If the photocaged selenocysteine molecule is toxic at the concentrations 
employed, lower concentrations can be tested until an optimal concentration is found. 
Additionally, another DNA library can be tested that might be better suited to undergo 
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selection for an aminoacyl tRNA synthetase that recognizes the photocaged 
selenocysteine molecule. In addition to another DNA library, other types of plasmids can 
be used to incorporate photocaged selenocysteine. Attempts were made to use a pUltra Se 
plasmid; however, attempts at incorporation of photocaged selenocysteine were 
unsuccessful. Further investigation into the pUltra plasmids is necessary before further 
rounds of selection take place. 
Experimental 
General: Solvents and reagents were obtained from either Sigma Aldrich or Fischer 
Scientific and used without further purification. Reactions were performed in ambient 
conditions with non-distilled solvents. 1% Agarose gels were imaged using a BioRad 
Molecular Imager (Gel Doc XR+). 
1-carboxy-2-((2-nitrobenzyl)selanyl)ethan-1-aminium: To a flame dried vial was 
added L-selenocystine (1 eq., 100 mg, 0.302 mmol), NaOH (1.6 mL, 0.5 M), and EtOH 
(400 µL) before cooling vial to 0oC on ice. Once dissolved, NaBH4 (80 mg, 2.11 mmol) 
was added before the vial was removed from the ice and allowed to stir until warmed to 
room temperature. The vial was then placed back on ice before dI H2O (640 µL) and 
NaOH (160 µL, 10M) were added along with nitrobenzyl bromide (excess, 262 mg, 1.21 
mmol). The reaction was stirred for 2.5 hours at room temperature before being quenched 
with HCl (1.3 mL, 2M) and concentrated using a rotary evaporator. The reaction was 
purified using flash chromatography (gradient: 10:1 DCM:MeOH to 1:1 DCM:EtOAc) to 
yield the product as a yellow solid (100 mg, 0.033 mmol , 55.5% yield). 1H NMR (400 
MHz; CDCl3): ∂ 7.97 (d, J=7.1 Hz, 1 H), 7.55 (t, J=6.3 Hz, 1 H), 7.38 (m, 2 H),  4.02 (d, 
J=4.3, 2H), 3.62 (m, 2 H).   
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10X M9 Salt Solution Preparation: For one liter: Dissolve salts in amounts below in 
800 mL dI water and adjust the pH to 7.2 with NaOH. Add water to a final volume of 1 
L. Autoclave (15 min, 121oC) or pass through a sterile filter. 
Na2HPO4-2H2O 75.2 g 
KH2PO4 30 g 
NaCl 5 g 
NH4Cl 5 g 
 
ppm012345678910
  
OH2N
O
Se
O2N
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100X Trace Elements Solution Preparation: For one liter, Dissolve 5 g EDTA in 800 
mL dI water. Adjust the pH to 7.5 with NaOH. Add components listed below and add 
water to a final volume of 1 liter. Sterilize by passing through a 0.22 µm filter.  
FeCl3-6H2O 0.83 g 
ZnCl2 84 mg 
CuCl2-2H2O 13 mg 
CoCl2-2H2O 10 mg 
H3BO3 10 mg 
MnCl2-4H2O 1.6 mg 
 
GMML Media Preparation: For 100 mL GMML Media 
2M MgSO4 50 µL 
1M CaCl2 10 µL 
5M NaCl 1.72 mL 
30mM L-Leu 1 mL 
50% Glycerol 2 mL 
10X M9 Salts 10 mL 
0.2 mg/mL 
Biotin 
500 µL 
5 mg/mL 
Thiamine 
100 µL 
Trace Elements Solution 100 µL 
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Pouring selection plates: Dissolved 2 g BactoAgar in 50 mL dI H2O. The BactoAgar 
was autocloaved, with a separate Erlenmeyer of 50 mL dI H2O. Once done, put in warm 
water bath while adding same amounts of solutions from table directly above (under 
“making GMML media”). In addition, added tetracycline (25 mg/mL, 100 µL), 
chloramphenicol, (50 mg/mL, 100 µL), kanamycin (50 mg/mL, 100 µL), ampicillin (50 
mg/mL, 100 µL), and 1 mL of UAA (1 mL of 10 mM photocaged selenocysteine). Added 
autoclaved dI water to bring solution to 100 mL, then poured plates immediately before 
BactoAgar solidified. 
Selenocysteine Selection: A previously prepared aliquot of 3D library was added to 500 
µL GMML media and incubated at 37oC for 2 hours with photocaged selenocysteine (5 
µL, 10mM) before plating (165 µL) on BactoAgar solution prepared above. The plates 
were incubated at 37oC for 2 days before scraping cells into 700 µL LB media. DNA was 
extracted using an IBI Scientific High-Speed Plasmid Mini kit according to 
manufacturer’s protocol and then purified by agarose gel electrophoresis (100 V, X hr) 
before gel extraction using an Omega E.Z.N.A. Gel Extraction kit according to 
manufacturer’s protocol. DNA was cleaned and concentrated using a Zymo DNA Clean 
& Concentrator kit according to manufacturer’s protocol and then stored at -80oC. 
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